prednisone has been researched along with Pemphigus Foliaceus in 397 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine the efficacy of dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris (PV)." | 9.13 | Multicenter randomized, double-blind, placebo-controlled, clinical trial of dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris. ( Albrecht, J; Chen, D; Fivenson, D; Jacobus, D; Pandya, AG; Rico, MJ; Werth, VP, 2008) |
| " The control group consisted of seven patients with pemphigus who had received prednisone and azathioprine." | 9.09 | Pemphigus vulgaris: benefits of tetracycline as adjuvant therapy in a series of thirteen patients. ( Calebotta, A; Carvalho, M; Castillo, R; González, F; Sáenz, AM, 1999) |
| "Methotrexate is historically recognized as an effective treatment of pemphigus but its utility as a single or alternate steroid-sparing agent was not recognized in recent consensus recommendations in pemphigus management." | 8.12 | Assessing the use of methotrexate as an alternate therapy for pemphigus vulgaris and pemphigus foliaceus. ( Adotama, P; Cymerman, R; Fruchter, R; Kolla, A; Shah, P; Soter, NA, 2022) |
| "Although azathioprine (AZA) combined with corticosteroids remains the first-line therapy to treat patients with pemphigus vulgaris (PV), there are increasing reports of AZA-induced leukopenia, which provides the rationale for monitoring the blood cell count and testing the genotypes at the thiopurine methyltransferase (TPMT) and the nucleoside diphosphate-linked moiety X-type motif 15 (NUDT15) genes." | 7.96 | Complete remission of refractory pemphigus vulgaris in a Chinese patient with mutated NUDT15 by combination of minimal doses of azathioprine and prednisone. ( Lan, TJ; Li, W; Shrestha, K; Zhan, TY; Zhou, XL; Zhou, YH, 2020) |
| " low dose oral prednisone on alternate days plus azathioprine every day (Lever's mini treatment: LMT) in oral pemphigus." | 7.77 | High dose oral prednisone vs. prednisone plus azathioprine for the treatment of oral pemphigus: a retrospective, bi-centre, comparative study. ( Apalla, Z; Chaidemenos, G; Ioannides, D; Koussidou, T; Papagarifallou, I, 2011) |
| "To evaluate the efficacy and safety of prednisone as monotherapy and in combination with the three most popular adjuvant agents - azathioprine, cyclosporine (ciclosporin), and cyclophosphamide - in the treatment of pemphigus vulgaris." | 7.74 | Efficacy and safety of cyclophosphamide, azathioprine, and cyclosporine (ciclosporin) as adjuvant drugs in pemphigus vulgaris. ( Blaszczyk, M; Cwikla, J; Kolacinska-Strasz, Z; Labecka, H; Natorska, U; Olszewska, M; Sulej, J, 2007) |
| " An apparent link is described between the use of MMF with prednisone to treat pemphigus vulgaris and the development of red blood cell anemia." | 7.74 | Red blood cell anemia in a patient with pemphigus vulgaris induced by the use of mycophenolate mofetil and prednisone. ( Scheinfeld, N, 2007) |
| "To determine the effect of dapsone on glucocorticoid-dependent patients with active or maintenance-phase pemphigus vulgaris." | 7.73 | Dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris. ( Albrecht, J; Heaphy, MR; Werth, VP, 2005) |
| " The criteria for inclusion were the clinical diagnosis of pemphigus, confirmed by histological examination and direct immunofluorescence and first line therapy using the "Lever scheme" protocol, combining 40 mg of prednisone on alternate days and 100 mg/day of azathioprine." | 7.72 | [Treatment of pemphigus vulgaris by azathioprine and low doses of prednisone (Lever scheme)]. ( Bedane, C; Benoit Corven, C; Carvalho, P; Chosidow, O; Joly, P; Noblesse, I; Prost, C; Roujeau, JC; Saiag, P; Verret, JL; Young, P, 2003) |
| "We retrospectively reviewed the medical records of 9 patients with pemphigus (7 with pemphigus vulgaris and 2 with pemphigus foliaceus) in whom therapy with other immunosuppressive regimens failed and who were subsequently treated with chlorambucil and prednisone." | 7.70 | The use of chlorambucil with prednisone in the treatment of pemphigus. ( Elgart, GW; Green, AR; Kerdel, F; Shah, N, 2000) |
| "The aim of the present study was to evaluate the efficacy and safety of combined treatment with prednisone and cyclosporine compared with prednisone alone in patients with pemphigus." | 7.69 | The efficacy of combined treatment with prednisone and cyclosporine in patients with pemphigus: preliminary study. ( Ben-Amitai, D; David, M; Katzenelson, V; Lapidoth, M; Lustig, S; Sandbank, M, 1994) |
| "Five patients with severe pemphigus vulgaris refractory to conventional therapy with azathioprine and corticosteroids were treated with cyclophosphamide, vincristine and prednisone." | 7.68 | Cyclophosphamide plus vincristine and prednisone in the treatment of severe pemphigus vulgaris refractory to conventional therapy. ( Aricò, M; Citarrella, P; Di Marco, P; Gebbia, V; Noto, G; Tambone Reyes, M, 1992) |
| "Between 1974 and 1981, thirteen patients with pemphigus vulgaris were treated with prednisone supplemented by gold salts." | 7.67 | Pemphigus vulgaris: results of treatment with gold as a steroid-sparing agent in a series of thirteen patients. ( Muller, SA; Perry, HO; Poulin, Y, 1984) |
| "Auranofin (AF), an oral gold salt, was given for 9-18 months to 3 patients with pemphigus vulgaris." | 7.67 | Oral gold therapy (Auranofin) in pemphigus vulgaris. ( Salomon, D; Saurat, JH, 1986) |
| "Prednisone is a widely used medication in dermatology, particularly in pemphigus patients." | 7.67 | Estimation of prednisone intake in pemphigus vulgaris patients with the use of simple laboratory methods. ( Feuerman, EJ; Kaufman, H; Maayan, R; Segal, R, 1987) |
| "Six patients with pemphigus vulgaris (PV) who had been treated unsuccessfully with other modalities and who were maintained on prednisone for disease control were started on levamisole in addition to their minimum effective dose of prednisone (40 to 80 mg." | 7.66 | Pemphigus vulgaris. A study of six cases treated with levamisole and prednisone. ( Cram, D; Lozada, F; Silverman, S, 1982) |
| "Penicillamine-induced pemphigus is an uncommon but well-recognized phenomenon." | 7.66 | Penicillamine-induced pemphigus foliaceus. A fatal outcome. ( Bailin, PL; Matkaluk, RM, 1981) |
| "2 women, 62 and 69 years old, both suffering from rheumatoid arthritis, were treated for 1 and 1 1/2 years, respectively, with penicillamine." | 7.66 | Two cases of penicillamine-induced pemphigus erythematosus. ( Thorvaldsen, J, 1979) |
| "This is a report on two cases with pemphigus vulgaris effectively controlled by dapsone." | 7.66 | Dapsone in the treatment of pemphigus vulgaris. ( Friedman-Birnbaum, R; Haim, S, 1978) |
| "Non-blinded trials of pemphigus vulgaris suggest that mycophenolate mofetil (MMF) may be beneficial." | 6.75 | Treating pemphigus vulgaris with prednisone and mycophenolate mofetil: a multicenter, randomized, placebo-controlled trial. ( Anhalt, GJ; Beissert, S; Kalia, V; Kanwar, AJ; Mimouni, D; Solomons, N, 2010) |
| "Thalidomide is a medication with strong anti-inflammatory, immunomodulatory, antiangiogenic, and sedative properties." | 5.56 | Thalidomide as a potential adjuvant treatment for paraneoplastic pemphigus: A single-center experience. ( Pan, M; Wang, J; Zhang, Y, 2020) |
| "Dapsone is a chemotherapeutic agent with anti-inflammatory properties that is used as a steroid-sparing agent in PV." | 5.43 | Efficacy of Dapsone in the Treatment of Pemphigus Vulgaris: A Single-Center Case Study. ( Barzilai, A; Baum, S; Debby, A; Gilboa, S; Trau, H, 2016) |
| "Paraneoplastic pemphigus is a life-threatening autoimmune bullous disease associated with neoplasia, generally of lymphoid origin." | 5.33 | Paraneoplastic pemphigus associated with non-Hodgkin B-cell lymphoma and good response to prednisone. ( Baradad, M; Herrero, C; Iranzo, P; Llambrich, A; Martínez De Pablo, MI; Mascaró, JM, 2005) |
| "Pemphigus vulgaris is a rare auto-immune blistering disease that can also be life-threatening." | 5.32 | Disseminated cellulitic cryptococcosis in the setting of prednisone monotherapy for pemphigus vulgaris. ( Anhalt, G; Barrett, T; Tran, M; Vonderheid, EC; Yoo, SS, 2003) |
| "One week after treatment, diabetes mellitus was diagnosed on the basis of blood and urine test results." | 5.28 | Diabetes mellitus induced in a dog after administration of corticosteroids and methylprednisolone pulse therapy. ( Jeffers, JG; Schick, RO; Shanley, KJ, 1991) |
| "Dapsone was easily withdrawn at the onset of remission." | 5.27 | Use of cyclophosphamide in azathioprine failures in pemphigus. ( Ahmed, AR; Hombal, S, 1987) |
| "A case of childhood pemphigus is reported." | 5.26 | Childhood pemphigus treated with gold. ( Laude, TA; Paltzik, RL, 1978) |
| "To determine the efficacy of dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris (PV)." | 5.13 | Multicenter randomized, double-blind, placebo-controlled, clinical trial of dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris. ( Albrecht, J; Chen, D; Fivenson, D; Jacobus, D; Pandya, AG; Rico, MJ; Werth, VP, 2008) |
| " The control group consisted of seven patients with pemphigus who had received prednisone and azathioprine." | 5.09 | Pemphigus vulgaris: benefits of tetracycline as adjuvant therapy in a series of thirteen patients. ( Calebotta, A; Carvalho, M; Castillo, R; González, F; Sáenz, AM, 1999) |
| "Patients with pemphigus vulgaris may occasionally present the highly active, widespread form of the disease, and/or maybe resistant to conventional oral steroid therapy, and/or manifest significant side effects from the prolonged use of high oral prednisone dosage." | 5.08 | Steroid-pulse therapy in pemphigus vulgaris long term follow-up. ( Chaidemenos, GC; Chryssomallis, F; Dimitriades, A; Karakatsanis, G; Panagiotides, D, 1995) |
| "A 77-year-old woman developed Kaposi's sarcoma (KS) during prednisone therapy for pemphigus foliaceus." | 4.77 | Pemphigus and Kaposi's sarcoma. ( Ahmed, AR; Israel, SR; Kaplan, RP, 1989) |
| "Methotrexate is historically recognized as an effective treatment of pemphigus but its utility as a single or alternate steroid-sparing agent was not recognized in recent consensus recommendations in pemphigus management." | 4.12 | Assessing the use of methotrexate as an alternate therapy for pemphigus vulgaris and pemphigus foliaceus. ( Adotama, P; Cymerman, R; Fruchter, R; Kolla, A; Shah, P; Soter, NA, 2022) |
| "Although azathioprine (AZA) combined with corticosteroids remains the first-line therapy to treat patients with pemphigus vulgaris (PV), there are increasing reports of AZA-induced leukopenia, which provides the rationale for monitoring the blood cell count and testing the genotypes at the thiopurine methyltransferase (TPMT) and the nucleoside diphosphate-linked moiety X-type motif 15 (NUDT15) genes." | 3.96 | Complete remission of refractory pemphigus vulgaris in a Chinese patient with mutated NUDT15 by combination of minimal doses of azathioprine and prednisone. ( Lan, TJ; Li, W; Shrestha, K; Zhan, TY; Zhou, XL; Zhou, YH, 2020) |
| "To describe and compare disease course outcomes and morbidity among patients with moderate to severe pemphigus who received rituximab therapy (RT) in addition to prednisone and CAT, versus those who were treated with prednisone and CAT alone." | 3.88 | Comparison of rituximab and conventional adjuvant therapy for pemphigus vulgaris: A retrospective analysis. ( Agarwal, A; Bañez, LL; Cardones, AR; Hall, RP, 2018) |
| "Nine patients with recalcitrant pemphigus were treated with prednisone, immunosuppressive agents, and/or intravenous immunoglobulin." | 3.78 | Effect of a single-cycle alternative dosing regimen for rituximab for recalcitrant pemphigus: a case series of 9 patients. ( Knowles, SR; Matsukura, S; Shear, NH; Walsh, S, 2012) |
| " low dose oral prednisone on alternate days plus azathioprine every day (Lever's mini treatment: LMT) in oral pemphigus." | 3.77 | High dose oral prednisone vs. prednisone plus azathioprine for the treatment of oral pemphigus: a retrospective, bi-centre, comparative study. ( Apalla, Z; Chaidemenos, G; Ioannides, D; Koussidou, T; Papagarifallou, I, 2011) |
| " Paraneoplastic pemphigus was diagnosed based on these findings; treatment was started with cyclophosphamide, doxorubicin, vincristin and prednisone." | 3.74 | Paraneoplastic pemphigus associated with non-Hodgkin lymphoma. ( Batista, MD; de Almeida, FA; Enokihara, MM; Lopes, RD; Michalany, NS; Takano, D, 2008) |
| "To evaluate the efficacy and safety of prednisone as monotherapy and in combination with the three most popular adjuvant agents - azathioprine, cyclosporine (ciclosporin), and cyclophosphamide - in the treatment of pemphigus vulgaris." | 3.74 | Efficacy and safety of cyclophosphamide, azathioprine, and cyclosporine (ciclosporin) as adjuvant drugs in pemphigus vulgaris. ( Blaszczyk, M; Cwikla, J; Kolacinska-Strasz, Z; Labecka, H; Natorska, U; Olszewska, M; Sulej, J, 2007) |
| " An apparent link is described between the use of MMF with prednisone to treat pemphigus vulgaris and the development of red blood cell anemia." | 3.74 | Red blood cell anemia in a patient with pemphigus vulgaris induced by the use of mycophenolate mofetil and prednisone. ( Scheinfeld, N, 2007) |
| "To determine the effect of dapsone on glucocorticoid-dependent patients with active or maintenance-phase pemphigus vulgaris." | 3.73 | Dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris. ( Albrecht, J; Heaphy, MR; Werth, VP, 2005) |
| "We report the case of a patient with a 13-year history of pemphigus vulgaris (PV) treated with immunosuppressive agents, prednisone and mycophenolate mofetil who had developed lesions of Kaposi's sarcoma (KS) on a sole plaque of PV that had been previously treated with intralesional injections of steroids." | 3.73 | Localized Kaposi's sarcoma in a patient with pemphigus vulgaris. ( Avalos-Peralta, P; Camacho, F; Herrera, A; Moreno-Ramírez, D; Pérez-Bernal, AM; Ríos-Martín, JJ, 2006) |
| " The criteria for inclusion were the clinical diagnosis of pemphigus, confirmed by histological examination and direct immunofluorescence and first line therapy using the "Lever scheme" protocol, combining 40 mg of prednisone on alternate days and 100 mg/day of azathioprine." | 3.72 | [Treatment of pemphigus vulgaris by azathioprine and low doses of prednisone (Lever scheme)]. ( Bedane, C; Benoit Corven, C; Carvalho, P; Chosidow, O; Joly, P; Noblesse, I; Prost, C; Roujeau, JC; Saiag, P; Verret, JL; Young, P, 2003) |
| " Recently there have been 6 reported cases of successful treatment of blistering autoimmune diseases with MMF in combination with high dose prednisone therapy." | 3.70 | Mycophenolate mofetil: a new therapeutic option in the treatment of blistering autoimmune diseases. ( Behrens, S; Grundmann-Kollmann, M; Kaskel, P; Kerscher, M; Korting, HC; Krähn, G; Leiter, U; Peter, RU, 1999) |
| "We retrospectively reviewed the medical records of 9 patients with pemphigus (7 with pemphigus vulgaris and 2 with pemphigus foliaceus) in whom therapy with other immunosuppressive regimens failed and who were subsequently treated with chlorambucil and prednisone." | 3.70 | The use of chlorambucil with prednisone in the treatment of pemphigus. ( Elgart, GW; Green, AR; Kerdel, F; Shah, N, 2000) |
| "A male patient who was being treated with oral prednisone for erosive mucocutaneous pemphigus lesions developed fever, jaundice, a rash, and anemia within 2 wk of starting dapsone therapy." | 3.69 | Sulfone syndrome in a patient receiving steroids for pemphigus. ( Barnard, GF; Dagher, RK; Scharf, MJ, 1994) |
| "The aim of the present study was to evaluate the efficacy and safety of combined treatment with prednisone and cyclosporine compared with prednisone alone in patients with pemphigus." | 3.69 | The efficacy of combined treatment with prednisone and cyclosporine in patients with pemphigus: preliminary study. ( Ben-Amitai, D; David, M; Katzenelson, V; Lapidoth, M; Lustig, S; Sandbank, M, 1994) |
| "Five patients with severe pemphigus vulgaris refractory to conventional therapy with azathioprine and corticosteroids were treated with cyclophosphamide, vincristine and prednisone." | 3.68 | Cyclophosphamide plus vincristine and prednisone in the treatment of severe pemphigus vulgaris refractory to conventional therapy. ( Aricò, M; Citarrella, P; Di Marco, P; Gebbia, V; Noto, G; Tambone Reyes, M, 1992) |
| "Between 1974 and 1981, thirteen patients with pemphigus vulgaris were treated with prednisone supplemented by gold salts." | 3.67 | Pemphigus vulgaris: results of treatment with gold as a steroid-sparing agent in a series of thirteen patients. ( Muller, SA; Perry, HO; Poulin, Y, 1984) |
| "A patient with pemphigus vulgaris had lesions on the lip that proved to be refractory to intralesional corticosteroid therapy and to treatment with azathioprine and later to daily administration of 250 mg of prednisone." | 3.67 | Surgical approach to the treatment of refractory lesions of pemphigus vulgaris. ( Abraham, Z; Haim, S; Hirshowitz, B, 1984) |
| "A patient with pemphigus foliaceus, derived from pemphigus erythematosus, developed Kaposi's sarcoma characterized by wide-spread skin nodules on the extremities after 5-month treatment with large doses of prednisone." | 3.67 | Kaposi's sarcoma after steroid therapy for pemphigus foliaceus. ( Huang, RK; Huang, YZ; Qian, XC, 1989) |
| "Auranofin (AF), an oral gold salt, was given for 9-18 months to 3 patients with pemphigus vulgaris." | 3.67 | Oral gold therapy (Auranofin) in pemphigus vulgaris. ( Salomon, D; Saurat, JH, 1986) |
| "Severe cases of pemphigus vulgaris should be treated with prednisone in high dosage (180-360 mg daily)." | 3.67 | [Therapy of pemphigus and pemphigoid]. ( Schaumburg-Lever, G, 1986) |
| "We present the cases of two female patients with pemphigus foliaceus and pemphigus erythematosus, respectively, who did not respond to long-term azathioprine and prednisone treatment in high dosages." | 3.67 | [Cyclosporin A in the treatment of pemphigus foliaceus and pemphigus erythematosus]. ( Balda, BR; Rosenzweig, D, 1986) |
| "Prednisone is a widely used medication in dermatology, particularly in pemphigus patients." | 3.67 | Estimation of prednisone intake in pemphigus vulgaris patients with the use of simple laboratory methods. ( Feuerman, EJ; Kaufman, H; Maayan, R; Segal, R, 1987) |
| "Six patients with pemphigus vulgaris (PV) who had been treated unsuccessfully with other modalities and who were maintained on prednisone for disease control were started on levamisole in addition to their minimum effective dose of prednisone (40 to 80 mg." | 3.66 | Pemphigus vulgaris. A study of six cases treated with levamisole and prednisone. ( Cram, D; Lozada, F; Silverman, S, 1982) |
| "Penicillamine-induced pemphigus is an uncommon but well-recognized phenomenon." | 3.66 | Penicillamine-induced pemphigus foliaceus. A fatal outcome. ( Bailin, PL; Matkaluk, RM, 1981) |
| "A rapidly growing squamous cell carcinoma developed in an area of active pemphigus vulgaris on the cheek of a 45-year-old woman during treatment with prednisone and cyclophosphamide." | 3.66 | Squamous cell carcinoma arising in pemphigus vulgaris during immunosuppressive therapy. ( Cramer, SF; Mahomed, Y; Mandel, MA; Michel, B, 1980) |
| "2 women, 62 and 69 years old, both suffering from rheumatoid arthritis, were treated for 1 and 1 1/2 years, respectively, with penicillamine." | 3.66 | Two cases of penicillamine-induced pemphigus erythematosus. ( Thorvaldsen, J, 1979) |
| "This is a report on two cases with pemphigus vulgaris effectively controlled by dapsone." | 3.66 | Dapsone in the treatment of pemphigus vulgaris. ( Friedman-Birnbaum, R; Haim, S, 1978) |
| "Herpesvirus hominis (HVH) hepatitis, a rarely recognized manifestation of HVH infection in adults, occurred in a 36-year-old woman who had received prednisone therapy for pemphigus vulgaris continuously for seven years." | 3.65 | Herpesvirus hominis hepatitis and disseminated intravascular coagulation. Occurrence in an adult with pemphigus vulgaris. ( Bryant, J; Keane, JT; Levin, S; Malkinson, FD, 1976) |
| "A Mexican-American patient with pemphigus vulgaris developed fatal disseminated coccidioidomycosis while on immunosuppressive therapy with systemic corticosteroids and azathioprine." | 3.65 | Pemphigus vulgaris and disseminated coccidioidomycosis. ( Jacobs, PH; Krulig, L; Loeffel, D, 1976) |
| "In total, 27 patients with pemphigus vulgaris were included: nine newly diagnosed (33%) and 18 relapsing (67%); 11 had moderate disease (41%) and 16 moderate to severe (59%)." | 3.01 | Proof of concept for the clinical effects of oral rilzabrutinib, the first Bruton tyrosine kinase inhibitor for pemphigus vulgaris: the phase II BELIEVE study. ( Arora, P; Bassukas, ID; Baum, S; Caux, F; Gourlay, SG; Joly, P; Kern, JS; Murrell, DF; Neale, A; Patsatsi, A; Roussaki-Schulze, AV; Sinclair, R; Stavropoulos, P; Thomas, D; Werth, VP; Zeeli, T, 2021) |
| "What's already known about this topic? Pemphigus vulgaris (PV) is the most common type of pemphigus." | 2.94 | Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid-sparing effect. ( Alexandre, M; Avenel-Audran, M; Bedane, C; Bénéton, N; Benichou, J; Bernard, P; Beylot-Barry, M; Bouaziz, JD; Caillot, F; Calbo, S; Caux, F; Chen, DM; Cheu, M; Csinady, E; D'Incan, M; Debarbieux, S; Delaporte, E; Dereure, O; Dupin, N; Dupuy, A; Duvert-Lehembre, S; Gearhart, L; Golinski, ML; Hebert, V; Houivet, E; Ingen-Housz-Oro, S; Joly, P; Jullien, D; Labeille, B; Lehane, P; Machet, L; Maho-Vaillant, M; Misery, L; Musette, P; Odueyungbo, A; Paul, C; Picard-Dahan, C; Prost-Squarcioni, C; Quereux, G; Richard, MA; Sassolas, B; Vabres, P, 2020) |
| "First-line treatment of pemphigus with rituximab results in a slightly greater cost compared with a standard CS regimen." | 2.94 | Comparison of real costs in the French healthcare system in newly diagnosed patients with pemphigus for first-line treatment with rituximab vs. standard corticosteroid regimen: data from a national multicentre trial. ( Bénichou, J; Hébert, V; Joly, P; Mignard, C; Tanguy, L; Tedbirt, B; Vermeulin, T, 2020) |
| "Non-blinded trials of pemphigus vulgaris suggest that mycophenolate mofetil (MMF) may be beneficial." | 2.75 | Treating pemphigus vulgaris with prednisone and mycophenolate mofetil: a multicenter, randomized, placebo-controlled trial. ( Anhalt, GJ; Beissert, S; Kalia, V; Kanwar, AJ; Mimouni, D; Solomons, N, 2010) |
| "We report an interesting case of nocardiosis-characterized by pulmonary intra-cavitary infection, in a 54-year-old man with PF and diabetes mellitus." | 2.72 | Pulmonary nocardiosis in a patient with pemphigus foliaceus: case report and literature review. ( Chen, C; Chen, M; He, Y; Li, X; Liang, M; Liu, S; Luo, N; Singh, S; Tan, S; Yang, W, 2021) |
| "Pemphigus vulgaris is a potentially life-threatening disease characterized by cutaneous and mucosal blistering." | 2.70 | Pemphigus vulgaris with oral involvement: evaluation of two different systemic corticosteroid therapeutic protocols. ( Femiano, F; Gombos, F; Scully, C, 2002) |
| "Oral pemphigus is considered to represent either an initial stage of pemphigus vulgaris that should be treated with high doses of immunosuppressive drugs to prevent its spread to the skin or a variety of the disease that does not need aggressive treatment." | 2.67 | Treatment of oral pemphigus vulgaris. ( Chrysomallis, F; Ioannides, D; Minas, A; Panagiotidou, D; Teknetzis, A, 1994) |
| "Pemphigus is an autoimmune bullous disease that involves skin and mucous membranes caused by autoantibodies against antigens on the surface of keratinocytes." | 2.49 | [Cutaneous pemphigus vulgaris. A case report]. ( Bello, C; González, S; Mondaca-Cornejo, L; Navarrete-Dechent, C, 2013) |
| "Pemphigus vulgaris is an infrequent but life-threatening autoimmune blistering disease that is rare in the pediatric age." | 2.46 | Rituximab in childhood pemphigus vulgaris: a long-term follow-up case and review of the literature. ( Fuertes, I; Guilabert, A; Iranzo, P; Mascaró, JM, 2010) |
| "Prednisone was used in 37 of 49 (75%) patients with doses ranging from 5 to 300 mg/day (mean 152." | 2.45 | Pemphigus vulgaris in pregnancy: analysis of current data on the management and outcomes. ( Ahmed, RA; Gürcan, HM; Kardos, M; Levine, D, 2009) |
| "Pemphigus is an autoimmune blistering disease that is rare in children and adolescents, but all clinical types of pemphigus occur in children." | 2.42 | [Pemphigus in children and adolescents]. ( Bowszyc-Dmochowska, M; Dańczak-Pazdrowska, A; Dmochowski, M; Hasse-Cieślińska, M; Silny, W, 2004) |
| "Paraneoplastic pemphigus has been established as a newly recognized but distinctive syndrome." | 2.40 | Paraneoplastic pemphigus. ( Anhalt, GJ, 1997) |
| "Twelve cases of oral pemphigus vulgaris are described to illustrate the long-term behavior of the disease and the treatment challenges it presents to the oral medicine practitioner." | 2.40 | Oral pemphigus vulgaris: a review of the literature and a report on the management of 12 cases. ( Frieden, I; Lozada-Nur, F; Robinson, JC, 1997) |
| "We report chronic lymphocytic leukemia-associated PNP in a patient who presented with extensive and debilitating painful oral ulcerations and received ablative therapy." | 2.40 | Immunoablative high-dose cyclophosphamide without stem cell rescue in paraneoplastic pemphigus: report of a case and review of this new therapy for severe autoimmune disease. ( Anhalt, GJ; Brodsky, RA; Grever, MR; Jones, RJ; Nousari, HC, 1999) |
| " The patient has been free of lesions with a maintenance dosage of 10 mg of prednisone every other day." | 2.39 | Pemphigus vulgaris in adolescence. A case presentation and review of the literature. ( Gorsky, M; Raviv, E; Raviv, M, 1994) |
| "Esophageal involvement in pemphigus vulgaris is rare, found more in women than in men, and can be the only manifestation of pemphigus." | 2.39 | A case of pemphigus vulgaris with esophageal involvement. ( Amichai, B; Finkelstein, E; Gasper, N; Grunwald, MH; Halevy, S, 1996) |
| "Multiple dermatofibromas have been previously reported in ten patients with autoimmune disorders; in six of these, the lesions initially appeared several months after commencing treatment with immunosuppressive medications." | 2.38 | Multiple dermatofibromas in patients with autoimmune disorders receiving immunosuppressive therapy. ( Cohen, PR, 1991) |
| "Pemphigus is not a contraindication to vaccination, although it may be worse or present as a first onset." | 1.91 | Pemphigus vulgaris after the second dose of COVID-19 vaccination: a case report. ( Khalayli, N; Kudsi, M; Omar, A, 2023) |
| "Rituximab treatment for pemphigus has only recently been introduced to the Israeli health basket." | 1.62 | Treatment of Pemphigus Vulgaris and Foliaceus with Adjuvant Rituximab Compared to Immunosuppression Alone: Real-Life Experience. ( Hodak, E; Leshem, YA; Levi, A; Mimouni, D; Snast, I; Spitzer, L, 2021) |
| " 2 weeks, and the average daily dosage of steroid was 1." | 1.62 | Short-Term Intravenous Infusion of Cyclophosphamide in the Treatment of Refractory Pemphigus Vulgaris: A Retrospective Study. ( Lai, K; Peng, X; Wei, S; Xie, S; Zeng, K; Zhang, W; Zhang, Z, 2021) |
| "However, further progress in the treatment of pemphigus requires their validation." | 1.56 | Results of the guideline-based treatment for pemphigus: a single-centre experience with 84 cases. ( Amagai, M; Funakoshi, T; Kakuta, R; Kurihara, Y; Miyamoto, J; Tanikawa, A; Yamagami, J, 2020) |
| "She was diagnosed with pemphigus vulgaris by skin biopsy about 3 months before hospitalization." | 1.56 | Aggressive refractory pemphigus vulgaris that responded to plasmapheresis: a case report. ( Hasan, A; Kassem, T; Khaddour, HH; Zaher, D, 2020) |
| "Thalidomide is a medication with strong anti-inflammatory, immunomodulatory, antiangiogenic, and sedative properties." | 1.56 | Thalidomide as a potential adjuvant treatment for paraneoplastic pemphigus: A single-center experience. ( Pan, M; Wang, J; Zhang, Y, 2020) |
| "Pemphigus vegetans is a rare variant of pemphigus vulgaris, characterized by vegetative lesions that develop mainly in flexural areas." | 1.56 | Hallopeau type of pemphigus vegetans, an unusual clinical presentation of an infrequent disease. ( Casas-Barrera, MA; Castellanos-Angarita, A; Cuellar, I; Mejia, M, 2020) |
| "Pemphigus vulgaris is chronic bullous disease that manifests as bullae and erosions of skin and mucosas, with intraepidermal suprabasal cleft formation seen in the histological examination." | 1.51 | Pemphigus vegetans with isolated involvement of the nose and chest: rare variant of pemphigus vulgaris. ( Feitoza, RIC; Ferreira, SAD; Santos, M; Schettini, MDCA, 2019) |
| "Pemphigus is a severe autoimmune blistering disease mediated by pathogenic anti-desmoglein antibodies leading to an inter keratinocyte disjunction." | 1.48 | Rituximab in pemphigus. ( Hebert, V; Joly, P, 2018) |
| "He was diagnosed with follicular lymphoma (Ann Arbor stage IVA) and PNP-related BO." | 1.46 | Achievement of the longest survival of paraneoplastic pemphigus with bronchiolitis obliterans associated with follicular lymphoma using R-CHOP chemotherapy. ( Hashimoto, T; Imamura, S; Ishii, N; Kamiya, K; Kinoshita, K; Lee, S; Yamauchi, T, 2017) |
| "Pemphigus foliaceus is a chronic autoimmune disease of the skin, clinically characterized by scaly and crusty cutaneous erosions involving the seborrheic areas." | 1.46 | Pemphigus foliaceus with pustular presentation in a patient with psoriasis. ( Gripp, AC; Pereira, DDN; Santana, CNLEL; Sousa, VB, 2017) |
| "Glucocorticoids are the first-line treatment for pemphigus vulgaris." | 1.43 | Yearly reduction of glucocorticoid dose by 50% as tapering schedule achieves complete remission for 124 pemphigus vulgaris patients. ( Chen, X; Gao, Y; Peng, Y; Wang, M; Zhao, J; Zhu, X, 2016) |
| " The pemphigus disease area index (PDAI) score, direct immunofluorescence (DIF), indirect immunofluorescence (IIF), and corticosteroid dosage were evaluated before IVIG therapy, after each cycle, and at 6 and 12 months' follow up." | 1.43 | IVIG therapy in pemphigus vulgaris has corticosteroid-sparing and immunomodulatory effects. ( Svecova, D, 2016) |
| "Dapsone is a chemotherapeutic agent with anti-inflammatory properties that is used as a steroid-sparing agent in PV." | 1.43 | Efficacy of Dapsone in the Treatment of Pemphigus Vulgaris: A Single-Center Case Study. ( Barzilai, A; Baum, S; Debby, A; Gilboa, S; Trau, H, 2016) |
| "His keloids were treated with intralesional corticosteroids with some improvement." | 1.42 | Extensive keloid formation after pemphigus vulgaris. ( Sako, EY; Workwick, S, 2015) |
| "Pemphigus vulgaris is rare in pregnancy and active PV presents potential threats of fetal spread and transient lesion production, which is associated with increased mortality and morbidity in the fetus." | 1.40 | Pemphigus vulgaris in pregnancy. ( Gero, MJ; Ragsdale, BD; Salzberg, KW, 2014) |
| " There were no adverse drug-related events and its use resulted in a significant reduction in steroid dosage during follow-up." | 1.39 | Adjuvant rituximab therapy in pemphigus: a single-center experience of 18 cases. ( Barzilai, A; Baum, S; Gilboa, S; Greenberger, S; Pavlotsky, F; Trau, H, 2013) |
| "Eighty patients with pemphigus vulgaris, 47 with pemphigus foliaceus, and 7 with paraneoplastic pemphigus were included." | 1.39 | Assessment of the rate of long-term complete remission off therapy in patients with pemphigus treated with different regimens including medium- and high-dose corticosteroids. ( Almugairen, N; Bedane, C; D'incan, M; Duvert-Lehembre, S; Hospital, V; Houivet, E; Joly, P; Picard, D; Tronquoy, AF, 2013) |
| "Pemphigus is a severe and life-threatening autoimmune bullous dermatosis." | 1.39 | The course and prognosis of pemphigus in 47 Tunisian patients. ( Ben Alaya, N; Fazaa, B; Kaffel, N; Khaled, A; Kharfi, M; Souissi, A; Taazayet, SB; Zeglaoui, F; Zermani, R, 2013) |
| " The dosage of prednisone was safely tapered using MMF, and the patient did not experience any flares or significant side effects during the course of treatment." | 1.39 | Mycophenolate mofetil as a first-line steroid-sparing agent in the treatment of pemphigus vulgaris. ( Cohen, GF; Patel, NS; Vyas, N, 2013) |
| "Pemphigus vulgaris is a bullous auto-immune disease affecting the skin and mucosa." | 1.39 | [Pemphigus vulgaris: an unusual clinical presentation]. ( Benhiba, H; Guerouaz, N; Hamada, S; Hassam, B; Saidi, A; Senouci, K, 2013) |
| "Every relapse was treated with rituximab (500 mg) without corticosteroids, which induced a new complete response." | 1.38 | Therapy with rituximab for autoimmune pemphigus: results from a single-center observational study on 42 cases with long-term follow-up. ( Cianchini, G; Corona, R; De Pità, O; Lupi, F; Masini, C; Puddu, P, 2012) |
| "We reported two cases of pemphigus vulgaris that received systemic treatment associated with low-level laser therapy for oral and cutaneous lesions." | 1.38 | Low-level laser therapy on the treatment of oral and cutaneous pemphigus vulgaris: case report. ( Almeida-Lopes, L; Barraviera, SR; Minicucci, EM; Miot, HA, 2012) |
| "We detected the presence of varicella zoster virus, as well as strong positivity for α-1 antitrypsin in the heart, kidneys, spleen, liver, skin, brain, lungs, pancreas, small and large intestines, and skeletal muscle." | 1.38 | Varicella-zoster virus (VZV) and alpha 1 antitrypsin: a fatal outcome in a patient affected by endemic pemphigus foliaceus. ( Abreu Velez, AM; Arias, LF; Dudley, SC; Gao, W; Grossniklaus, HE; Howard, MS; Jiao, Z; Smoller, BR, 2012) |
| "We report three adolescents with pemphigus vulgaris whose disease started at the age of 13, 15 and 14 years, respectively." | 1.37 | Pemphigus vulgaris in three adolescents: the course of the disease. ( Djakovic, Z; Medenica, L; Nikolic, M; Popadic, S; Skiljevic, D, 2011) |
| " The use of systemic corticosteroids in pemphigus has dramatically reduced its mortality rate, but the long-term use of steroids leads to severe side effects, many of which are serious." | 1.35 | Rituximab in refractory pemphigus vulgaris. ( Aricò, M; Bongiorno, MR; Sorce, M, 2008) |
| "The treatment of pemphigus vulgaris is generally regarded as difficult." | 1.35 | Successful treatment of pemphigus vulgaris with etanercept in four patients. ( Carter, JD; Glass, LF; Marcum, CB; Shetty, A, 2009) |
| "Pemphigus is a rare, life-threatening, acquired autoimmune bullous dermatosis." | 1.34 | Pemphigus vulgaris and pemphigus foliaceus: similar prognosis? ( Boubaker, S; Dhahri, AB; Hsairi, M; Makni, S; Mokni, M; Sellami, M; Zaraa, I; Zitouni, M, 2007) |
| "A patient with a conjunctival blister was diagnosed with pemphigus vulgaris by immunofluorescence tests performed on a conjunctival biopsy." | 1.33 | [Conjunctival blistering associated with pemphigus vulgaris: report of a case]. ( Alvarez, MA; Bianciotto, C; Herreras Cantalapiedra, JM; Méndez Díaz, MC, 2005) |
| "Paraneoplastic pemphigus is a life-threatening autoimmune bullous disease associated with neoplasia, generally of lymphoid origin." | 1.33 | Paraneoplastic pemphigus associated with non-Hodgkin B-cell lymphoma and good response to prednisone. ( Baradad, M; Herrero, C; Iranzo, P; Llambrich, A; Martínez De Pablo, MI; Mascaró, JM, 2005) |
| "Juvenile pemphigus vulgaris (JPV) is a rare autoimmune disease." | 1.33 | [Treatment of juvenile pemphigus vulgaris with intravenous immunoglobulins]. ( Buchvald, D; Danilla, T; Szép, Z, 2005) |
| " All patients responded with complete remission of symptomatology and had a prednisone dosage reduction until 70%." | 1.32 | Plasmapheresis therapy in pemphigus vulgaris and bullous pemphigoid. ( Da Ponte, C; De Roia, D; Guerra, R; Mazzi, G; Orazi, BM; Raineri, A; Santarossa, L; Zanolli, FA, 2003) |
| "Pemphigus vulgaris is a rare auto-immune blistering disease that can also be life-threatening." | 1.32 | Disseminated cellulitic cryptococcosis in the setting of prednisone monotherapy for pemphigus vulgaris. ( Anhalt, G; Barrett, T; Tran, M; Vonderheid, EC; Yoo, SS, 2003) |
| "Pemphigus vulgaris is a potentially fatal autoimmune blistering disease that is rare in childhood." | 1.32 | Pemphigus vulgaris: the eyes have it. ( Merchant, S; Weinstein, M, 2003) |
| "Pemphigus is an autoimmune blistering disease of the skin and mucous membranes." | 1.32 | Development of pemphigus herpetiformis in a patient with psoriasis receiving UV-light treatment. ( Chan, LS; Sanchez-Palacios, C, 2004) |
| "The following information was documented in each of the 15 patients before and after the initiation of IVIg therapy: total dosage and total duration of prednisone therapy and number of relapses." | 1.31 | Corticosteroid-sparing effect of intravenous immunoglobulin therapy in patients with pemphigus vulgaris. ( Ahmed, AR; Qureshi, A; Ruocco, E; Sami, N, 2002) |
| "Early diagnosis and treatment of pemphigus vulgaris allow a better prognosis with lower mortality rates." | 1.31 | Pemphigus vulgaris: a review of treatment over a 19-year period. ( Brenner, S; Budimcić, D; Lipozencić, J; Ljubojević, S, 2002) |
| "Paraneoplastic pemphigus is an autoimmune disease of the skin and mucosa described in 1990." | 1.31 | [Paraneoplastic pemphigus: a pustular form during chronic lymphoid leukemia]. ( Huttenberger, B; Jan, V; Joly, P; Lorette, G; Machet, MC; Martin, L; Rivollier, C; Vaillant, L, 2001) |
| "We describe a patient with acquired haemophilia A and pemphigus, who presented with spontaneous haematomas of the extremities." | 1.30 | A patient with acquired haemophilia A and pemphigus. ( Halbertsma, FJ; Mauser-Bunschoten, EP; van der Linden, PW, 1998) |
| "Reasonable therapeutic dosage regimen for pemphigus are analyzed to find the factors related to prognosis." | 1.30 | [A clinical analysis of 64 cases of pemphigus]. ( He, Z; Wang, B; Yu, B, 1998) |
| "Seventy-four of 79 patients with pemphigus vulgaris/vegetans and 24 of the 26 with pemphigus erythematosus/foliaceus were given corticosteroid treatment." | 1.29 | Feasibility of a registry of pemphigus in Italy: two years experience. Gruppo Italiano Studi Epidemiologici in Dermatologia (GISED) ( Bertoni, M; Cainelli, T; Naldi, L, 1993) |
| "In Tunisia, pemphigus is similar to Brazilian pemphigus with high frequency and predominant superficial forms (pemphigus foliaceus)." | 1.29 | [Tunisian pemphigus. Apropos of 70 cases. (Experience of the dermatology department of La Rabta Hospital 1974-1992)]. ( Ben Hamida, A; Ben Osman, A; Chaffai, M; Haouet, H; Haouet, S, 1996) |
| "Pemphigus is a group of chronic blistering diseases in which acantholysis and blister formation occur within the epidermis." | 1.29 | Bilateral herpes simplex virus keratitis in a patient with pemphigus vulgaris. ( Takeshita, T, 1996) |
| "Fifteen patients, all of whom had pemphigus vulgaris, were included in the analysis." | 1.29 | Treatment of pemphigus vulgaris with brief, high-dose intravenous glucocorticoids. ( Werth, VP, 1996) |
| "Paraneoplastic pemphigus is an autoimmune bullous disease described by precise clinical, histological and immunological features presented by Anhalt in 1990." | 1.29 | [Paraneoplastic pemphigus in chronic lymphocytic leukemia]. ( Belaïch, S; Bouscarat, F; Crickx, B; Descamps, V; Fournier, B; Gardin, P; Grossin, M; Joly, P; Le Bozec, P, 1996) |
| "The conjunctiva later became scarred with foreshortening of the fornices and development of symblepharon." | 1.28 | Paraneoplastic pemphigus, cicatricial conjunctivitis, and acanthosis nigricans with pachydermatoglyphy in a patient with bronchogenic squamous cell carcinoma. ( Folberg, R; Goeken, JA; Krachmer, JH; Lam, S; Massicotte, SJ; Smith, AC; Stone, MS, 1992) |
| "One week after treatment, diabetes mellitus was diagnosed on the basis of blood and urine test results." | 1.28 | Diabetes mellitus induced in a dog after administration of corticosteroids and methylprednisolone pulse therapy. ( Jeffers, JG; Schick, RO; Shanley, KJ, 1991) |
| " Higher dosage of prednisolone or prednisone more than 120 mg/day has never been used." | 1.28 | Treatment of pemphigus. ( Ophaswongse, S; Piamphongsant, T, 1991) |
| "Only 35 cases of juvenile pemphigus vulgaris have been reported in the literature up until to now." | 1.28 | Juvenile pemphigus vulgaris. ( Graff-Lonnevig, V; Kaaman, T, 1991) |
| "Familial pemphigus vulgaris was found in a Jewish woman and her son who developed the disease within a period of 18 months from one another." | 1.28 | Familial pemphigus vulgaris. ( David, M; Idises, C; Katzenelson, V; Mellibovsky, J; Sandbank, M; Zamir, R, 1990) |
| "Dapsone is a helpful adjuvant to therapy." | 1.27 | Juvenile pemphigus. ( Ahmed, AR; Salm, M, 1983) |
| "Acute vesicular or weeping dermatoses are best treated with cool, wet compresses and topical lotions, whereas dry, scaly skin conditions should be treated with hydrating measures and topical ointments." | 1.27 | Dermatologic emergencies. ( Rapini, RP, 1986) |
| " The mean initial steroid dosage was 87 mg prednisone equivalent per day." | 1.27 | [Therapy of pemphigus. Critical remarks based on 44 clinical cases]. ( Smolle, J, 1985) |
| "Of four corticosteroid-resistant pemphigus vulgaris patients, all improved after cyclosporine addition to corticosteroids." | 1.27 | Treatment of nine cases of pemphigus vulgaris with cyclosporine. ( Barthelemy, H; Cambazard, F; Claudy, AL; Frappaz, A; Kanitakis, J; Mauduit, G; Rouchouse, B; Souteyrand, P; Thivolet, J, 1988) |
| "Pemphigus vulgaris is rare in the young and this may lead to misdiagnosis and inappropriate therapy." | 1.27 | Juvenile pemphigus vulgaris. A case report. ( Dyer, RB; Jacyk, WK, 1987) |
| "Dapsone was easily withdrawn at the onset of remission." | 1.27 | Use of cyclophosphamide in azathioprine failures in pemphigus. ( Ahmed, AR; Hombal, S, 1987) |
| "Pemphigus is an autoimmune bullous dermatosis in which intercellular antibodies are associated with loss of intercellular cohesion." | 1.27 | Chronic balanitis owing to pemphigus vegetans. ( Castle, WN; Clendenning, WE; Schwartz, BK; Selikowitz, SM; Wentzell, JM, 1987) |
| "Treatment with prednisone and azathioprine resulted in the disappearance of vetetating lesions and in healing, with postinflammatory hyperpigmentation." | 1.26 | Pyodermite végétante of Hallopeau. Immunofluorescence studies performed in an early disease stage. ( Faber, WR; Neumann, HA, 1980) |
| "Pemphigus is frequently a fatal skin disease." | 1.26 | Death in pemphigus. ( Ahmed, AR; Moy, R, 1982) |
| "Twenty-eight cases of intraoral pemphigus vulgaris are presented." | 1.26 | Intraoral pemphigus vulgaris. ( Zegarelli, DJ; Zegarelli, EV, 1977) |
| "In two patients with pemphigus vulgaris a rash identical with that seen in disseminated superficial porokeratosis developed on the trunk and extremities during periods in which they were receiving relatively high doses of steroids." | 1.26 | Disseminated superficial porokeratosis in patients with pemphigus vulgaris treated with steroids. ( Feuerman, EJ; Sandbank, M, 1979) |
| "A case of childhood pemphigus is reported." | 1.26 | Childhood pemphigus treated with gold. ( Laude, TA; Paltzik, RL, 1978) |
| "A patient with pemphigus vulgaris and serious side effects of steroid therapy was treated by exchange plasmapheresis." | 1.26 | Plasmapheresis and immunosuppressive therapy. Effect on levels of intercellular antibodies in pemphigus vulgaris. ( Auerbach, R; Bystryn, JC, 1979) |
| "Pemphigus is an erosive disease of the skin and mucous membranes, characterized by intraepidermal blisters, acantholysis of epidermal cells and a serum antibody directed to an antigen at the intercellular space." | 1.26 | Pemphigus and pemphigoid: dermatologic examples of type II immune reactivity. ( Sams, WM, 1976) |
| " Mortality and morbidity closely correlated with the corticosteroid dosage used to attain control." | 1.26 | Pemphigus: a 20-year review of 107 patients treated with corticosteroids. ( Nelson, CT; Rosenberg, FR; Sanders, S, 1976) |
| "A patient with pemphigus vulgaris, treated with long term corticosteroids, developed avascular necrosis of the head of the femur and humerus, bilaterally." | 1.24 | Avascular bone necrosis. A complication of long-term corticosteroid therapy. ( Epstein, JH; Epstein, NN; Tuffanelli, DL, 1965) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 186 (46.85) | 18.7374 |
| 1990's | 63 (15.87) | 18.2507 |
| 2000's | 59 (14.86) | 29.6817 |
| 2010's | 65 (16.37) | 24.3611 |
| 2020's | 24 (6.05) | 2.80 |
| Authors | Studies |
|---|---|
| Goebeler, M | 1 |
| Bata-Csörgő, Z | 1 |
| De Simone, C | 1 |
| Didona, B | 1 |
| Remenyik, E | 2 |
| Reznichenko, N | 1 |
| Stoevesandt, J | 1 |
| Ward, ES | 1 |
| Parys, W | 1 |
| de Haard, H | 1 |
| Dupuy, P | 1 |
| Verheesen, P | 1 |
| Schmidt, E | 1 |
| Joly, P | 14 |
| Hatami, P | 1 |
| Balighi, K | 1 |
| Mohandesi, NA | 1 |
| Nicknam Asl, H | 1 |
| Aryanian, Z | 1 |
| Kolla, A | 1 |
| Shah, P | 1 |
| Cymerman, R | 1 |
| Fruchter, R | 1 |
| Adotama, P | 1 |
| Soter, NA | 1 |
| Khalayli, N | 1 |
| Omar, A | 1 |
| Kudsi, M | 1 |
| Chen, DM | 1 |
| Odueyungbo, A | 1 |
| Csinady, E | 1 |
| Gearhart, L | 1 |
| Lehane, P | 1 |
| Cheu, M | 1 |
| Maho-Vaillant, M | 2 |
| Prost-Squarcioni, C | 2 |
| Hebert, V | 4 |
| Houivet, E | 3 |
| Calbo, S | 1 |
| Caillot, F | 1 |
| Golinski, ML | 2 |
| Labeille, B | 2 |
| Picard-Dahan, C | 2 |
| Paul, C | 1 |
| Richard, MA | 2 |
| Bouaziz, JD | 2 |
| Duvert-Lehembre, S | 3 |
| Bernard, P | 4 |
| Caux, F | 4 |
| Alexandre, M | 2 |
| Ingen-Housz-Oro, S | 2 |
| Vabres, P | 2 |
| Delaporte, E | 4 |
| Quereux, G | 2 |
| Dupuy, A | 2 |
| Debarbieux, S | 2 |
| Avenel-Audran, M | 2 |
| D'Incan, M | 5 |
| Bedane, C | 5 |
| Bénéton, N | 2 |
| Jullien, D | 2 |
| Dupin, N | 2 |
| Misery, L | 2 |
| Machet, L | 2 |
| Beylot-Barry, M | 2 |
| Dereure, O | 2 |
| Sassolas, B | 2 |
| Benichou, J | 3 |
| Musette, P | 3 |
| Feitoza, RIC | 1 |
| Santos, M | 1 |
| Schettini, MDCA | 1 |
| Ferreira, SAD | 1 |
| Vermeulin, T | 1 |
| Tanguy, L | 1 |
| Tedbirt, B | 1 |
| Mignard, C | 2 |
| Frampton, JE | 1 |
| Kakuta, R | 1 |
| Kurihara, Y | 1 |
| Yamagami, J | 1 |
| Miyamoto, J | 1 |
| Funakoshi, T | 1 |
| Tanikawa, A | 1 |
| Amagai, M | 1 |
| Abbas, A | 1 |
| Flowers, RH | 1 |
| Noland, MB | 1 |
| Gru, AA | 1 |
| Chen, X | 2 |
| Yang, YM | 1 |
| Li, B | 1 |
| Li, XQ | 1 |
| Zhou, C | 1 |
| Jin, J | 1 |
| Cai, L | 1 |
| Zhang, JZ | 1 |
| Mu, ZL | 1 |
| Russo, I | 1 |
| Miotto, S | 1 |
| Saponeri, A | 1 |
| Alaibac, M | 1 |
| Balayé, P | 1 |
| Calbo, SB | 1 |
| Konstantinou, MP | 1 |
| Chaby, G | 1 |
| Ayoubi, N | 1 |
| Rudnick, E | 1 |
| Motaparthi, K | 1 |
| Bhatia, SM | 1 |
| Streilein, RD | 2 |
| Hall, RP | 3 |
| Khaddour, HH | 1 |
| Zaher, D | 1 |
| Kassem, T | 1 |
| Hasan, A | 1 |
| Zhou, XL | 1 |
| Zhan, TY | 1 |
| Zhou, YH | 1 |
| Shrestha, K | 1 |
| Lan, TJ | 1 |
| Li, W | 1 |
| Snast, I | 1 |
| Spitzer, L | 1 |
| Hodak, E | 2 |
| Levi, A | 1 |
| Mimouni, D | 4 |
| Leshem, YA | 2 |
| Zhang, W | 1 |
| Wei, S | 1 |
| Peng, X | 1 |
| Xie, S | 1 |
| Zhang, Z | 1 |
| Zeng, K | 1 |
| Lai, K | 1 |
| Wang, J | 1 |
| Zhang, Y | 1 |
| Pan, M | 1 |
| Cao, L | 1 |
| Wang, F | 1 |
| Du, XY | 1 |
| Zhu, HY | 1 |
| Wang, L | 1 |
| Xu, W | 1 |
| Li, JY | 1 |
| Fan, L | 1 |
| Cuellar, I | 1 |
| Mejia, M | 1 |
| Castellanos-Angarita, A | 1 |
| Casas-Barrera, MA | 1 |
| Luo, N | 1 |
| Tan, S | 1 |
| Li, X | 1 |
| Liu, S | 1 |
| Singh, S | 1 |
| Chen, M | 1 |
| Yang, W | 1 |
| He, Y | 1 |
| Chen, C | 1 |
| Liang, M | 1 |
| Murrell, DF | 3 |
| Patsatsi, A | 1 |
| Stavropoulos, P | 1 |
| Baum, S | 6 |
| Zeeli, T | 1 |
| Kern, JS | 1 |
| Roussaki-Schulze, AV | 1 |
| Sinclair, R | 1 |
| Bassukas, ID | 1 |
| Thomas, D | 1 |
| Neale, A | 1 |
| Arora, P | 1 |
| Werth, VP | 5 |
| Gourlay, SG | 1 |
| Maeda, T | 1 |
| Yanagi, T | 1 |
| Imafuku, K | 1 |
| Kitamura, S | 1 |
| Hata, H | 1 |
| Izumi, K | 1 |
| Ujiie, H | 1 |
| Iwata, H | 1 |
| Shimizu, H | 1 |
| Lee, S | 1 |
| Yamauchi, T | 1 |
| Ishii, N | 2 |
| Hashimoto, T | 7 |
| Kinoshita, K | 1 |
| Imamura, S | 1 |
| Kamiya, K | 1 |
| Garje, R | 1 |
| Chau, JJ | 1 |
| Chung, J | 1 |
| Wanat, K | 1 |
| Zakharia, Y | 1 |
| Sprecher, E | 1 |
| Sousa, VB | 1 |
| Santana, CNLEL | 1 |
| Pereira, DDN | 1 |
| Gripp, AC | 1 |
| Tani, N | 1 |
| Sugita, K | 1 |
| Yamada, N | 1 |
| Yamamoto, O | 1 |
| Shiraishi, K | 1 |
| Sayama, K | 1 |
| Krase, IZ | 1 |
| Wickenheiser, M | 1 |
| Chao, J | 1 |
| Kurtzman, D | 1 |
| Segal, R | 2 |
| Culpepper, K | 1 |
| Shi, V | 1 |
| Agarwal, A | 1 |
| Bañez, LL | 1 |
| Cardones, AR | 1 |
| Gómez Moyano, E | 1 |
| Ayala Blanca, M | 1 |
| Martínez Pilar, L | 1 |
| Bray, ER | 1 |
| Bray, FN | 1 |
| Herskovitz, I | 1 |
| Cho-Vega, JH | 1 |
| Apalla, Z | 2 |
| Sotiriou, E | 1 |
| Lazaridou, E | 1 |
| Manousari, A | 1 |
| Trigoni, A | 1 |
| Papagarifallou, I | 2 |
| Ioannides, D | 3 |
| Gilboa, S | 2 |
| Greenberger, S | 1 |
| Pavlotsky, F | 1 |
| Trau, H | 5 |
| Barzilai, A | 5 |
| Almugairen, N | 1 |
| Hospital, V | 1 |
| Picard, D | 1 |
| Tronquoy, AF | 1 |
| Bello, C | 1 |
| Mondaca-Cornejo, L | 1 |
| Navarrete-Dechent, C | 1 |
| González, S | 1 |
| Lévy-Sitbon, C | 1 |
| Reguiaï, Z | 1 |
| Durlach, A | 1 |
| Goeldel, AL | 1 |
| Grange, F | 1 |
| Moreno, AC | 1 |
| Santi, CG | 1 |
| Gabbi, TV | 1 |
| Aoki, V | 1 |
| Maruta, CW | 1 |
| Gdalevich, M | 1 |
| Ziv, M | 1 |
| David, M | 9 |
| Fairley, J | 1 |
| Woodley, D | 1 |
| Hannah, D | 1 |
| McKillip, J | 1 |
| Okawa, J | 1 |
| Rose, M | 1 |
| Keyes-Elstein, LL | 1 |
| Pinckney, A | 1 |
| Overington, A | 1 |
| Wedgwood, J | 1 |
| Ding, L | 1 |
| Welch, B | 1 |
| Adah, A | 1 |
| Hill, K | 1 |
| Wyatt, J | 1 |
| Didion, L | 1 |
| Salzberg, KW | 1 |
| Gero, MJ | 1 |
| Ragsdale, BD | 1 |
| Blair, RV | 1 |
| Wakamatsu, N | 1 |
| Pucheu-Haston, CM | 1 |
| Tirado-Sánchez, A | 1 |
| Bonifaz, A | 1 |
| Ponce-Olivera, RM | 1 |
| Barnadas, MA | 1 |
| Rubiales, MV | 1 |
| Gich, I | 1 |
| Gelpí, C | 1 |
| Sinha, AA | 1 |
| González-Serrano, J | 1 |
| Paredes, VM | 1 |
| López-Pintor, RM | 1 |
| de Arriba, L | 1 |
| Hernández, G | 1 |
| Wang, M | 1 |
| Gao, Y | 1 |
| Peng, Y | 1 |
| Zhao, J | 1 |
| Zhu, X | 1 |
| Svecova, D | 1 |
| Sako, EY | 1 |
| Workwick, S | 1 |
| Astman, N | 1 |
| Berco, E | 1 |
| Solomon, M | 1 |
| Gissi, DB | 1 |
| Tarsitano, A | 1 |
| Baldovini, C | 1 |
| Gabusi, A | 1 |
| Galvañ-Pérez Del Pulgar, JI | 1 |
| Tercedor-Sánchez, J | 1 |
| Jiménez-Gallo, D | 1 |
| Linares-Barrios, M | 1 |
| Debby, A | 1 |
| Lehman, JS | 1 |
| Mueller, KK | 1 |
| Schraith, DF | 1 |
| Lo Schiavo, A | 1 |
| Sangiuliano, S | 1 |
| Puca, RV | 1 |
| Brunetti, G | 1 |
| Ruocco, E | 2 |
| Cozzi, R | 1 |
| Batista, MD | 1 |
| Takano, D | 1 |
| Lopes, RD | 1 |
| Enokihara, MM | 1 |
| Michalany, NS | 1 |
| de Almeida, FA | 1 |
| Sorce, M | 1 |
| Aricò, M | 3 |
| Bongiorno, MR | 2 |
| Daulat, S | 1 |
| Detweiler, JG | 1 |
| Pandya, AG | 2 |
| Breton, AL | 1 |
| Chandeclerc, ML | 1 |
| Lefaure, C | 1 |
| Cuny, JF | 1 |
| Barbaud, A | 1 |
| Schmutz, JL | 1 |
| Ma, DL | 1 |
| Fang, K | 1 |
| Qasmi, S | 1 |
| Aoussar, A | 1 |
| Senouci, K | 2 |
| Khabbal, Y | 1 |
| Abouqual, R | 1 |
| Hassam, B | 2 |
| Belgnaoui, FZ | 1 |
| Abasq, C | 1 |
| Mouquet, H | 2 |
| Gilbert, D | 2 |
| Tron, F | 2 |
| Grassi, V | 1 |
| Eccersley, LR | 1 |
| Hoffbrand, AV | 1 |
| Rustin, MH | 1 |
| McNamara, CJ | 1 |
| Kardos, M | 1 |
| Levine, D | 1 |
| Gürcan, HM | 1 |
| Ahmed, RA | 1 |
| Shetty, A | 1 |
| Marcum, CB | 1 |
| Glass, LF | 1 |
| Carter, JD | 1 |
| Grover, RK | 1 |
| Stites, PC | 1 |
| Helm, TN | 1 |
| Beutner, EH | 4 |
| Masu, T | 1 |
| Okuyama, R | 1 |
| Tsunoda, T | 1 |
| Aiba, S | 2 |
| Fuertes, I | 1 |
| Guilabert, A | 1 |
| Mascaró, JM | 2 |
| Iranzo, P | 2 |
| Beissert, S | 1 |
| Kanwar, AJ | 1 |
| Solomons, N | 1 |
| Kalia, V | 1 |
| Anhalt, GJ | 9 |
| Menezes, N | 1 |
| Leite, I | 1 |
| Tente, D | 1 |
| Couceiro, A | 1 |
| Baptista, A | 1 |
| Varela, P | 1 |
| Zaraa, I | 2 |
| Kerkeni, N | 1 |
| Sellami, M | 2 |
| Chelly, I | 1 |
| Zitouna, M | 1 |
| Makni, S | 2 |
| Mokni, M | 2 |
| Ben Osman, A | 2 |
| Chaidemenos, G | 1 |
| Koussidou, T | 3 |
| Pistone, G | 1 |
| Doukaki, S | 1 |
| Strowd, LC | 1 |
| Taylor, SL | 1 |
| Jorizzo, JL | 1 |
| Namazi, MR | 1 |
| Moutran, R | 1 |
| Maatouk, I | 1 |
| Stephan, F | 1 |
| Halaby, E | 1 |
| Abadjian, G | 1 |
| Tomb, R | 1 |
| Mazzarolo, SS | 1 |
| Lyakhovitsky, A | 1 |
| Scope, A | 2 |
| Amichai, B | 2 |
| Rimer, J | 1 |
| Popadic, S | 1 |
| Medenica, L | 1 |
| Skiljevic, D | 1 |
| Djakovic, Z | 1 |
| Nikolic, M | 1 |
| Gürcan, H | 1 |
| Mabrouk, D | 1 |
| Razzaque Ahmed, A | 1 |
| Carlesimo, M | 1 |
| Abruzzese, C | 1 |
| Orsini, D | 1 |
| Narcisi, A | 1 |
| Cortesi, G | 1 |
| Mari, E | 1 |
| De Marco, G | 1 |
| Camplone, G | 1 |
| Hidalgo, I | 1 |
| Martinez, F | 1 |
| Grau, C | 1 |
| Gil, I | 1 |
| Azón, A | 1 |
| Craythorne, EE | 1 |
| Mufti, G | 1 |
| DuVivier, AW | 1 |
| Li, F | 1 |
| Jin, HZ | 1 |
| Su, F | 1 |
| Jia, L | 1 |
| Sun, QN | 1 |
| Khaled, A | 1 |
| Taazayet, SB | 1 |
| Ben Alaya, N | 1 |
| Souissi, A | 1 |
| Zeglaoui, F | 2 |
| Kaffel, N | 1 |
| Kharfi, M | 1 |
| Zermani, R | 1 |
| Fazaa, B | 2 |
| Wafa, A | 1 |
| Hicham, H | 1 |
| Yassir, A | 1 |
| Zoubida, TM | 1 |
| Mohamed, A | 2 |
| Amine, H | 1 |
| Abdelaziz, M | 1 |
| Cianchini, G | 1 |
| Lupi, F | 1 |
| Masini, C | 1 |
| Corona, R | 1 |
| Puddu, P | 1 |
| De Pità, O | 1 |
| Sigmund, GA | 1 |
| Oppenheimer, R | 1 |
| Matsukura, S | 1 |
| Knowles, SR | 1 |
| Walsh, S | 1 |
| Shear, NH | 1 |
| Minicucci, EM | 1 |
| Miot, HA | 1 |
| Barraviera, SR | 1 |
| Almeida-Lopes, L | 1 |
| Gharote, HP | 1 |
| Nair, PP | 1 |
| Kasetty, S | 1 |
| Thomas, S | 1 |
| Kulkarni, A | 1 |
| Lorente Lavirgen, AI | 1 |
| Bernabeu-Wittel, J | 1 |
| Dominguez-Cruz, J | 1 |
| Conejo-Mir, J | 1 |
| Abreu Velez, AM | 1 |
| Smoller, BR | 1 |
| Gao, W | 1 |
| Grossniklaus, HE | 1 |
| Jiao, Z | 1 |
| Arias, LF | 1 |
| Dudley, SC | 1 |
| Howard, MS | 1 |
| Asarch, A | 1 |
| Swick, BL | 1 |
| Fairley, JA | 1 |
| Leventhal, JS | 1 |
| Sanchez, MR | 1 |
| Vyas, N | 1 |
| Patel, NS | 1 |
| Cohen, GF | 1 |
| Benhiba, H | 1 |
| Hamada, S | 1 |
| Guerouaz, N | 1 |
| Saidi, A | 1 |
| Femiano, F | 1 |
| Gombos, F | 1 |
| Scully, C | 1 |
| Sami, N | 1 |
| Qureshi, A | 1 |
| Ahmed, AR | 8 |
| Verrini, A | 1 |
| Cannata, G | 1 |
| Cozzani, E | 1 |
| Terracini, M | 1 |
| Parodi, A | 1 |
| Rebora, A | 1 |
| Ljubojević, S | 1 |
| Lipozencić, J | 1 |
| Brenner, S | 1 |
| Budimcić, D | 1 |
| Benoit Corven, C | 1 |
| Carvalho, P | 1 |
| Prost, C | 1 |
| Verret, JL | 1 |
| Saiag, P | 1 |
| Noblesse, I | 1 |
| Chosidow, O | 1 |
| Young, P | 1 |
| Roujeau, JC | 5 |
| Mazzi, G | 1 |
| Raineri, A | 1 |
| Zanolli, FA | 1 |
| Da Ponte, C | 1 |
| De Roia, D | 1 |
| Santarossa, L | 1 |
| Guerra, R | 1 |
| Orazi, BM | 1 |
| Yoo, SS | 2 |
| Tran, M | 1 |
| Anhalt, G | 1 |
| Barrett, T | 2 |
| Vonderheid, EC | 1 |
| Nousari, CH | 1 |
| Brodsky, R | 1 |
| Merchant, S | 1 |
| Weinstein, M | 1 |
| Gergely, L | 1 |
| Váróczy, L | 1 |
| Vadász, G | 1 |
| Illés, A | 1 |
| CACCIALANZA, P | 1 |
| GOMEZ ORBANEJA, J | 1 |
| QUINONES, PA | 1 |
| RISCO, A | 1 |
| MORIAME, G | 1 |
| ZWIRNER, H | 1 |
| RAMIREZ, G | 1 |
| GONZALEZ RIOSECO, H | 1 |
| LEIGHEB, V | 1 |
| COHEN, N | 1 |
| HOFFMAN, WA | 1 |
| SPIRO, HM | 1 |
| FOLDVARI, F | 1 |
| THOROCZKAY, N | 1 |
| MASSZI, J | 1 |
| LEVER, WF | 10 |
| WHITE, H | 1 |
| TINOZZI, GC | 1 |
| BRUNI, L | 1 |
| VILANOVA, X | 1 |
| DEMORAGAS, JM | 1 |
| RICE, JS | 1 |
| HURT, WC | 1 |
| ROVIN, S | 1 |
| BERGOEND, H | 2 |
| PRIVITERA, A | 1 |
| CATELLI, P | 1 |
| LEDO, A | 1 |
| ROOK, A | 1 |
| SAUER, H | 1 |
| RAUSCH-STROOMANN, JG | 1 |
| SOENNICHSEN, N | 1 |
| APOSTOLOFF, G | 1 |
| RANDOW, U | 1 |
| EPSTEIN, NN | 2 |
| TUFFANELLI, DL | 2 |
| EPSTEIN, JH | 2 |
| MCELIN, TW | 1 |
| CROMER, DW | 1 |
| BHASKAR, SN | 1 |
| BELL, WB | 1 |
| NELSON, CT | 2 |
| KVICALOVA, E | 1 |
| STAVA, Z | 1 |
| TRAPL, J | 1 |
| Viglione, M | 1 |
| Stoopler, ET | 1 |
| Sollecito, TP | 1 |
| DeRossi, SS | 1 |
| Sanchez-Palacios, C | 1 |
| Chan, LS | 1 |
| Palleschi, GM | 2 |
| Giomi, B | 1 |
| Giacomelli, A | 1 |
| Cunha, PR | 1 |
| de Oliveira, JR | 1 |
| Salles, MJ | 1 |
| Jamora, J | 1 |
| Bystryn, JC | 6 |
| Sauret, J | 1 |
| Yale, S | 1 |
| Ahiarah, A | 1 |
| Hasse-Cieślińska, M | 1 |
| Dmochowski, M | 1 |
| Bowszyc-Dmochowska, M | 1 |
| Silny, W | 1 |
| Dańczak-Pazdrowska, A | 1 |
| Heaphy, MR | 1 |
| Albrecht, J | 2 |
| Bianciotto, C | 1 |
| Herreras Cantalapiedra, JM | 1 |
| Alvarez, MA | 1 |
| Méndez Díaz, MC | 1 |
| Martínez De Pablo, MI | 1 |
| Llambrich, A | 1 |
| Baradad, M | 1 |
| Herrero, C | 1 |
| Ben Lagha, N | 1 |
| Poulesquen, V | 1 |
| Alantar, A | 1 |
| Maman, L | 1 |
| Szép, Z | 1 |
| Danilla, T | 1 |
| Buchvald, D | 1 |
| Avalos-Peralta, P | 1 |
| Herrera, A | 1 |
| Ríos-Martín, JJ | 1 |
| Pérez-Bernal, AM | 2 |
| Moreno-Ramírez, D | 1 |
| Camacho, F | 2 |
| Torrelo, A | 1 |
| Mediero, IG | 1 |
| Colmenero, I | 1 |
| Zambrano, A | 1 |
| Masmoudi, A | 1 |
| Hadj Taieb, H | 1 |
| Ben Ayed, M | 1 |
| Abida, O | 1 |
| Makni, H | 1 |
| Turki, H | 1 |
| Masmoudi, H | 1 |
| Zahaf, A | 1 |
| Ahlers, KM | 1 |
| Seupaul, RA | 1 |
| Hall, J | 1 |
| Nicastro, A | 1 |
| Gabor, L | 1 |
| Azizi, E | 1 |
| Cummins, DL | 1 |
| Tzu, J | 1 |
| Owens, N | 1 |
| Meyerle, JH | 1 |
| Benchikhi, H | 1 |
| Ghafour, S | 1 |
| Disky, A | 1 |
| Janati, K | 1 |
| Bichra, L | 1 |
| Lakhdar, H | 1 |
| Olszewska, M | 3 |
| Kolacinska-Strasz, Z | 1 |
| Sulej, J | 1 |
| Labecka, H | 1 |
| Cwikla, J | 1 |
| Natorska, U | 1 |
| Blaszczyk, M | 4 |
| Gerlicz, Z | 1 |
| Scheinfeld, N | 1 |
| Jacquot, S | 1 |
| Gougeon, ML | 1 |
| Muller, R | 1 |
| Dreno, B | 1 |
| Doutre, MS | 1 |
| Pauwels, C | 1 |
| Franck, N | 1 |
| Picard, C | 1 |
| Tancrede-Bohin, E | 1 |
| Hertl, M | 1 |
| Hsairi, M | 1 |
| Boubaker, S | 1 |
| Zitouni, M | 1 |
| Dhahri, AB | 1 |
| Erdag, G | 1 |
| Qureshi, HS | 1 |
| Greer, KE | 1 |
| Patterson, JW | 1 |
| Chaidemenos, GCh | 1 |
| Mourellou, O | 2 |
| Tsatsou, F | 1 |
| Fivenson, D | 1 |
| Chen, D | 1 |
| Rico, MJ | 2 |
| Jacobus, D | 1 |
| Martin, LK | 1 |
| Tournadre, A | 1 |
| Amarger, S | 1 |
| Ristori, JM | 1 |
| Soubrier, M | 1 |
| Czernik, A | 1 |
| Silverstein, EH | 1 |
| Burnett, JW | 1 |
| Polano, MK | 1 |
| Miller, RC | 1 |
| Felman, YM | 1 |
| Hietanen, J | 1 |
| Salo, OP | 1 |
| Salm, M | 1 |
| Fleckman, P | 1 |
| Stenn, K | 1 |
| Patel, HP | 1 |
| Diaz, LA | 2 |
| Larsen, FS | 1 |
| Clausen, J | 1 |
| Blose, DA | 1 |
| Aki, HE | 1 |
| Sotto, MN | 1 |
| Sampaio, SA | 1 |
| Katz, M | 1 |
| Holubar, K | 1 |
| Golan, D | 1 |
| Gilhar, A | 1 |
| Shmuel, Z | 1 |
| Moshkowitz, M | 1 |
| Poulin, Y | 1 |
| Perry, HO | 2 |
| Muller, SA | 3 |
| Lynde, CW | 1 |
| Ongley, RC | 1 |
| Rigg, JM | 1 |
| Sienkiewicz, H | 1 |
| Jakubowicz, K | 1 |
| Vennemann, F | 1 |
| Schedel, A | 1 |
| Lorenzen, M | 1 |
| Schaumburg-Lever, G | 3 |
| Haim, S | 5 |
| Abraham, Z | 1 |
| Hirshowitz, B | 1 |
| Neumann, HA | 1 |
| Faber, WR | 1 |
| Andre, C | 1 |
| Joneau Fabre, M | 1 |
| Lauret, P | 1 |
| Flechet, ML | 1 |
| Kalis, B | 1 |
| Revuz, J | 1 |
| Touraine, R | 1 |
| Lozada, F | 1 |
| Silverman, S | 1 |
| Cram, D | 1 |
| Shohat, B | 1 |
| Feuerman, EJ | 4 |
| Stewart, WM | 1 |
| Sotiriou, L | 1 |
| Herszenson, S | 1 |
| Jordon, RE | 4 |
| Coverton, RW | 1 |
| Armstrong, RB | 1 |
| Webb, PK | 1 |
| Conant, MA | 1 |
| Maibach, HI | 1 |
| Ndiaye, A | 1 |
| Strobel, M | 1 |
| Ball, M | 1 |
| Marchand, JP | 1 |
| Ndiaye, B | 1 |
| Moy, R | 1 |
| Castro, RM | 1 |
| Proença, NG | 1 |
| Matkaluk, RM | 1 |
| Bailin, PL | 1 |
| Larrègue, M | 1 |
| Bressieux, JM | 1 |
| Bureau, B | 1 |
| Gallet, P | 1 |
| Rat, JP | 1 |
| Pinalie, A | 1 |
| de Giacomoni, P | 1 |
| Bruckner, N | 1 |
| Katz, RA | 1 |
| Hood, AF | 1 |
| Mahomed, Y | 1 |
| Mandel, MA | 1 |
| Cramer, SF | 1 |
| Michel, B | 1 |
| Daniel, Y | 1 |
| Shenhav, M | 2 |
| Botchan, A | 1 |
| Peyser, MR | 1 |
| Lessing, JB | 2 |
| Chryssomallis, F | 1 |
| Dimitriades, A | 1 |
| Chaidemenos, GC | 2 |
| Panagiotides, D | 1 |
| Karakatsanis, G | 1 |
| Kapetis, E | 1 |
| Chrysomallis, F | 1 |
| Teknetzis, A | 1 |
| Panagiotidou, D | 1 |
| Minas, A | 1 |
| Luisi, AF | 1 |
| Stoukides, CA | 1 |
| Barnard, GF | 1 |
| Scharf, MJ | 1 |
| Dagher, RK | 1 |
| Lyde, CB | 1 |
| Cox, SE | 1 |
| Cruz, PD | 1 |
| Machet, MC | 2 |
| Stephanov, E | 1 |
| Estève, E | 1 |
| De Closets, F | 1 |
| Barrabès, A | 1 |
| Thérizol-Ferly, M | 1 |
| Lebret, G | 1 |
| Grangeponte, MC | 1 |
| Vaillant, L | 2 |
| Schaller, J | 1 |
| Rohwedder, A | 1 |
| Breier, B | 1 |
| Werchau, H | 1 |
| Gorsky, M | 1 |
| Raviv, M | 1 |
| Raviv, E | 1 |
| Chorzelski, TP | 2 |
| Stefanato, CM | 1 |
| Stanley, JR | 2 |
| Korman, NJ | 1 |
| Maciejowska, E | 1 |
| Jablonska, S | 3 |
| Lapidoth, M | 1 |
| Ben-Amitai, D | 1 |
| Katzenelson, V | 2 |
| Lustig, S | 1 |
| Sandbank, M | 7 |
| Naldi, L | 1 |
| Bertoni, M | 1 |
| Cainelli, T | 1 |
| Tope, WD | 1 |
| Kamino, H | 1 |
| Briggaman, RA | 2 |
| Prose, NS | 1 |
| Berg, WA | 1 |
| Fishman, EK | 1 |
| Carson, PJ | 1 |
| Hameed, A | 1 |
| Haouet, H | 1 |
| Ben Hamida, A | 1 |
| Haouet, S | 1 |
| Chaffai, M | 1 |
| Panzarella, K | 1 |
| Camisa, C | 2 |
| Grunwald, MH | 1 |
| Gasper, N | 1 |
| Finkelstein, E | 1 |
| Halevy, S | 1 |
| Takeshita, T | 1 |
| Fournier, B | 1 |
| Bouscarat, F | 1 |
| Le Bozec, P | 1 |
| Gardin, P | 1 |
| Grossin, M | 2 |
| Descamps, V | 1 |
| Crickx, B | 1 |
| Belaïch, S | 1 |
| Bartalena, L | 1 |
| Bogazzi, F | 1 |
| Chiovato, L | 1 |
| Tanda, ML | 1 |
| Martino, E | 1 |
| Robinson, JC | 1 |
| Lozada-Nur, F | 1 |
| Frieden, I | 1 |
| Tehranchi-Nia, Z | 1 |
| Qureshi, TA | 1 |
| Thakur, BK | 1 |
| Bernardi, DM | 1 |
| Murali, MR | 1 |
| McClain, SA | 1 |
| Clark, RA | 1 |
| Agarwal, M | 1 |
| Walia, R | 1 |
| Kochhar, AM | 1 |
| Chander, R | 1 |
| Weston, WL | 1 |
| Friednash, M | 1 |
| Seline, P | 1 |
| Huff, JC | 1 |
| Morelli, JG | 1 |
| Saijyo, S | 1 |
| Tagami, H | 1 |
| Halbertsma, FJ | 1 |
| van der Linden, PW | 1 |
| Mauser-Bunschoten, EP | 1 |
| van der Waal, RI | 1 |
| Pas, HH | 1 |
| Schulten, EA | 1 |
| Jonkman, MF | 1 |
| Nieboer, C | 1 |
| Wang, BY | 1 |
| Krishnan, S | 1 |
| Isenberg, HD | 1 |
| Calebotta, A | 1 |
| Sáenz, AM | 1 |
| González, F | 1 |
| Carvalho, M | 1 |
| Castillo, R | 1 |
| Nousari, HC | 2 |
| Brodsky, RA | 1 |
| Jones, RJ | 1 |
| Grever, MR | 1 |
| Kimyai-Asadi, A | 1 |
| Ketabchi, N | 1 |
| Grundmann-Kollmann, M | 1 |
| Korting, HC | 1 |
| Behrens, S | 1 |
| Kaskel, P | 1 |
| Leiter, U | 1 |
| Krähn, G | 1 |
| Kerscher, M | 1 |
| Peter, RU | 1 |
| Fuxiang, G | 1 |
| Levine, N | 1 |
| Shah, N | 1 |
| Green, AR | 1 |
| Elgart, GW | 1 |
| Kerdel, F | 1 |
| Hale, EK | 1 |
| Fainaru, O | 1 |
| Mashiach, R | 1 |
| Kupferminc, M | 1 |
| Pauzner, D | 1 |
| Martín, FJ | 1 |
| He, Z | 1 |
| Wang, B | 1 |
| Yu, B | 1 |
| Rivollier, C | 1 |
| Martin, L | 1 |
| Jan, V | 1 |
| Huttenberger, B | 1 |
| Lorette, G | 1 |
| Goucha, S | 1 |
| Mokhtar, I | 1 |
| Yaalaoui, S | 1 |
| Kamoun, MR | 1 |
| Thorvaldsen, J | 1 |
| Keane, JT | 1 |
| Malkinson, FD | 1 |
| Bryant, J | 1 |
| Levin, S | 1 |
| Suter, L | 1 |
| Bilek, I | 1 |
| Vakilzadeh, F | 1 |
| Tolentino, AT | 1 |
| Zegarelli, DJ | 1 |
| Zegarelli, EV | 1 |
| Hirone, T | 1 |
| Paltzik, RL | 1 |
| Laude, TA | 1 |
| Rozsívalová, V | 2 |
| Lim, HW | 1 |
| Judd, KP | 1 |
| Auerbach, R | 1 |
| Sodaify, M | 1 |
| Vollum, DI | 1 |
| Hernández-Pérez, E | 1 |
| Friedman-Birnbaum, R | 1 |
| Godel, V | 1 |
| Regenbogen, L | 1 |
| Stein, R | 1 |
| Fellner, MJ | 1 |
| Katz, JM | 1 |
| McCabe, JB | 1 |
| Jauregui, HO | 1 |
| Lynch, PJ | 1 |
| Rather, EP | 1 |
| Rutala, PJ | 1 |
| Savin, JA | 1 |
| Sams, WM | 5 |
| Maize, JC | 1 |
| Dobson, RL | 1 |
| Provost, TT | 1 |
| Rosenberg, FR | 1 |
| Sanders, S | 1 |
| Penneys, NS | 2 |
| Eaglstein, WH | 2 |
| Frost, P | 2 |
| Osteen, FB | 1 |
| Wheeler, CE | 1 |
| Puritz, EM | 1 |
| Gange, RW | 1 |
| Rhodes, EL | 1 |
| Edwards, CO | 1 |
| Powell, ME | 1 |
| Nicholas, KC | 1 |
| Bays, RA | 1 |
| Lyon, ED | 1 |
| Kay, LW | 1 |
| Webster, SB | 1 |
| Piamphongsant, T | 2 |
| Sivayathorn, A | 1 |
| Krulig, L | 1 |
| Jacobs, PH | 1 |
| Loeffel, D | 1 |
| Citarrella, P | 1 |
| Gebbia, V | 1 |
| Di Marco, P | 1 |
| Tambone Reyes, M | 1 |
| Noto, G | 1 |
| Trott, MS | 1 |
| Hymes, SR | 1 |
| Lam, S | 1 |
| Stone, MS | 1 |
| Goeken, JA | 1 |
| Massicotte, SJ | 1 |
| Smith, AC | 1 |
| Folberg, R | 1 |
| Krachmer, JH | 1 |
| Cranin, AN | 1 |
| Campolmi, P | 1 |
| Bonan, P | 1 |
| Lotti, T | 1 |
| Fabbri, P | 1 |
| Panconesi, E | 1 |
| Ficarra, G | 1 |
| Jeffers, JG | 1 |
| Shanley, KJ | 1 |
| Schick, RO | 1 |
| Piette, F | 1 |
| Bourgeois-Droin, C | 1 |
| Granier, F | 1 |
| Pedreiro, J | 1 |
| Madinier, V | 1 |
| Ophaswongse, S | 1 |
| Graff-Lonnevig, V | 1 |
| Kaaman, T | 1 |
| Cohen, PR | 1 |
| Castro-Salomó, A | 1 |
| Porcel, JM | 1 |
| Ordi, J | 1 |
| Martínez-Costa, X | 1 |
| Vilardell, M | 1 |
| Vidal, J | 1 |
| Murdock, DK | 1 |
| Lookingbill, DP | 1 |
| Zamir, R | 1 |
| Mellibovsky, J | 1 |
| Idises, C | 1 |
| Lurie, R | 1 |
| Trattner, A | 1 |
| Rook, AH | 1 |
| Jegasothy, BV | 1 |
| Heald, P | 1 |
| Nahass, GT | 1 |
| Ditre, C | 1 |
| Witmer, WK | 1 |
| Lazarus, GS | 1 |
| Edelson, RL | 1 |
| Tan-Lim, R | 1 |
| Markitziu, A | 1 |
| Zafiropoulos, G | 1 |
| Flores de Jacoby, L | 1 |
| Pisanty, S | 1 |
| Usuba, Y | 1 |
| Hashimoto, K | 2 |
| Tanita, Y | 1 |
| Sakai, K | 1 |
| Qian, XC | 1 |
| Huang, YZ | 1 |
| Huang, RK | 1 |
| Weissman-Katzenelson, V | 1 |
| Ben-Chetrit, A | 1 |
| Hazaz, B | 1 |
| Ingber, A | 1 |
| Kaplan, RP | 1 |
| Israel, SR | 1 |
| Sanaknaki, BA | 1 |
| Kibbi, AG | 1 |
| Salman, SM | 1 |
| Zaynoun, ST | 1 |
| Rapini, RP | 1 |
| Neumann, RA | 1 |
| Knobler, RM | 1 |
| Metze, D | 1 |
| Jurecka, W | 1 |
| Smolle, J | 1 |
| Galimberti, RL | 1 |
| Kowalczuk, AM | 1 |
| Bianchi, O | 1 |
| Bonino, MV | 1 |
| Garcia Garcia, A | 1 |
| Salomon, D | 1 |
| Saurat, JH | 1 |
| Zaidenbaum, M | 2 |
| Seidenbaum, M | 1 |
| Fine, JD | 1 |
| Appell, ML | 1 |
| Green, LK | 1 |
| Barthelemy, H | 1 |
| Frappaz, A | 1 |
| Cambazard, F | 1 |
| Mauduit, G | 1 |
| Rouchouse, B | 1 |
| Kanitakis, J | 1 |
| Souteyrand, P | 1 |
| Claudy, AL | 1 |
| Thivolet, J | 1 |
| Robledo, MA | 1 |
| Prada, S | 1 |
| Jaramillo, D | 1 |
| Leon, W | 1 |
| Balda, BR | 1 |
| Rosenzweig, D | 1 |
| Hup, JM | 1 |
| Bruinsma, RA | 1 |
| Boersma, ER | 1 |
| de Jong, MC | 1 |
| Jones, SK | 1 |
| Schwab, HP | 1 |
| Norris, DA | 1 |
| Jacyk, WK | 1 |
| Dyer, RB | 1 |
| Sarubbi, FA | 1 |
| Hombal, S | 1 |
| Maayan, R | 1 |
| Kaufman, H | 1 |
| Kahana, M | 1 |
| Levy, A | 1 |
| Schewach-Millet, M | 1 |
| Eisenstein, Z | 1 |
| Ronnen, M | 1 |
| Feinstein, A | 1 |
| Castle, WN | 1 |
| Wentzell, JM | 1 |
| Schwartz, BK | 1 |
| Clendenning, WE | 1 |
| Selikowitz, SM | 1 |
| Ihrke, PJ | 2 |
| Stannard, AA | 2 |
| Ardans, AA | 2 |
| Griffin, CE | 2 |
| Kallet, AJ | 1 |
| Milgraum, SS | 1 |
| Kanzler, MH | 1 |
| Waldinger, TP | 1 |
| Wong, RC | 1 |
| Chorzelski, T | 4 |
| Daszynski, J | 1 |
| Jabłońska, S | 1 |
| Solomon, L | 1 |
| Von Weiss, JF | 1 |
| Indgin, S | 1 |
| Hollander, A | 1 |
| Emmerson, RW | 1 |
| Wilson-Jones, E | 1 |
| Kierland, RR | 1 |
| Winkelmann, RK | 1 |
| Peck, SM | 1 |
| Osserman, KE | 1 |
| Weiner, LB | 1 |
| Lefkovits, A | 1 |
| Osserman, RS | 1 |
| Bolgert, M | 1 |
| Le Sourd, M | 1 |
| Deluzenne, R | 1 |
| Burton, JL | 2 |
| Greaves, MW | 2 |
| Marks, J | 1 |
| Dawber, RP | 1 |
| Krain, LS | 3 |
| Bierman, SM | 1 |
| Orenstein, JM | 1 |
| Castadot, MJ | 1 |
| Wilens, SL | 1 |
| McMurchy, KA | 1 |
| Dick, HM | 1 |
| Roenigk, HH | 2 |
| Deodhar, S | 1 |
| Berger, BW | 1 |
| Maier, HS | 1 |
| Kantor, I | 1 |
| Wexler, DE | 1 |
| Voelter, WW | 1 |
| Newell, GB | 1 |
| Schwartz, SL | 1 |
| Bean, SF | 1 |
| Mullins, JF | 1 |
| Barranco, VP | 1 |
| Bushkell, LL | 1 |
| Goltz, RW | 1 |
| Landau, JW | 1 |
| Newcomer, VD | 1 |
| Stangeland, N | 1 |
| van Dijk, TJ | 1 |
| van Velde, JL | 1 |
| Sood, VD | 1 |
| Pasricha, JS | 1 |
| Medved, A | 1 |
| Maxwell, I | 1 |
| Kuch, J | 1 |
| Schroeter, A | 1 |
| Jorden, RE | 1 |
| Burnham, TK | 1 |
| Neblett, TR | 1 |
| Fine, G | 1 |
| Logan, WS | 1 |
| Tindall, JP | 1 |
| Elson, ML | 1 |
| Lebioda, J | 1 |
| Ogden, IW | 1 |
| Ashworth, CJ | 1 |
| Sacks, Y | 1 |
| Williams, LF | 1 |
| Byrne, JJ | 1 |
| Voiculescu, M | 1 |
| Vulcan, P | 1 |
| Stopler, T | 1 |
| Grimmer, H | 1 |
| Murphy, PJ | 1 |
| Harrell, ER | 1 |
| Stein, KM | 1 |
| Raque, CJ | 1 |
| Harrell, DD | 1 |
| Samitz, MH | 1 |
| Nebe, H | 1 |
| Sönnichsen, N | 1 |
| Elias, PM | 1 |
| Jarratt, M | 1 |
| Zalitis, IE | 1 |
| Catalanotto, FA | 1 |
| Thorne, E | 1 |
| Fusaro, R | 1 |
| Benderly, A | 1 |
| Shafrir, A | 2 |
| Levy, J | 1 |
| Hewitt, J | 1 |
| Lessana-Leibowitch, M | 1 |
| Benveniste, M | 1 |
| Saporta, L | 1 |
| Rollier, R | 1 |
| Bourra, A | 1 |
| Warczewski, ZJ | 1 |
| Devico, V | 1 |
| Khalifa, H | 1 |
| Mullan, R | 1 |
| Eggleston, DJ | 1 |
| Nally, F | 1 |
| Rocha, GL | 1 |
| Miranda, O | 1 |
| Ciuffo, D | 1 |
| Mesquita, A | 1 |
| Olivi, WR | 1 |
| Balassiano, E | 1 |
| Szrman, WH | 1 |
| Rassner, G | 1 |
| Wenig, KH | 1 |
| Indgin, SN | 1 |
| Katz, SI | 1 |
| Connor, JD | 1 |
| Puissant, A | 1 |
| Chérif-Cheikh, JL | 1 |
| David, V | 1 |
| Audebert, G | 1 |
| McKelvey, EM | 1 |
| Hasegawa, J | 1 |
| Rabhan, NB | 1 |
| Kopf, AW | 1 |
| Friedman, D | 1 |
| Paldi, E | 1 |
| Schuppli, R | 1 |
| Duverne, J | 1 |
| Mounier, R | 1 |
| Perret, MJ | 1 |
| Fowler-Bergfeld, W | 1 |
| Kraus, Z | 1 |
| Vortel, V | 1 |
| Strauss, JS | 1 |
| Wells, GC | 1 |
| Ballard, RM | 1 |
| Driscoll, AM | 1 |
| Krakowski, A | 1 |
| Covo, J | 1 |
| Rozanski, Z | 1 |
| Goldberg, HS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| An Open-label, Non-controlled, Phase II Study to Evaluate the Safety, Pharmacodynamics, Pharmacokinetics, Efficacy and Conditions of Use of ARGX-113 in Patients With Mild to Moderate Pemphigus (Vulgaris and Foliaceus)[NCT03334058] | Phase 2 | 34 participants (Actual) | Interventional | 2017-10-18 | Completed | ||
| Comparison Between Monoclonal Antibody CD20 Treatment (Rituximab (mabthéra))and General Corticotherapy Treatment in Patients With Pemphigus[NCT00784589] | Phase 3 | 90 participants (Anticipated) | Interventional | 2009-07-31 | Completed | ||
| Comparative Analysis of the Th17 Cellular Response in Active and Inactive Pemphigus Vulgaris Patients[NCT04096222] | 42 participants (Anticipated) | Observational | 2021-06-29 | Recruiting | |||
| A Randomized, Double-Blind, Placebo-Controlled Phase II Trial of Infliximab in Subjects With Pemphigus Vulgaris Receiving Prednisone[NCT00283712] | Phase 2 | 20 participants (Actual) | Interventional | 2006-03-31 | Completed | ||
| A Prospective, Randomised, Double-blind, Placebo-controlled, Parallel Group, Mult-center, 52-week Trial to Assess the Efficacy and Safety of Adjunct Mycophenolate Mofetil (MMF) to Achieve Remission With Reduced Corticosteroid in Subjects With Pemphigus Vu[NCT00683930] | Phase 3 | 96 participants (Actual) | Interventional | 2004-05-31 | Completed | ||
| Traitment of Patients Presenting Pemphigus With Anti CD20 (Mabthera).[NCT00213512] | Phase 2/Phase 3 | 22 participants | Interventional | 2003-06-30 | Completed | ||
| A Prospective Randomized Placebo-Controlled Clinical Trial of Dapsone as a Glucocorticoid-Sparing Agent in Maintenance Phase Pemphigus Vulgaris[NCT00429533] | Phase 2 | 48 participants | Interventional | 1996-11-30 | Terminated | ||
| Phase 2 Randomized Trial of IVIg With or Without Cyclophosphamide in Pemphigus[NCT00483119] | Phase 2 | 9 participants (Actual) | Interventional | 2007-04-30 | Terminated (stopped due to Study was terminated due to the death of the PI.) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Adverse events experienced by participants resulting in study treatment discontinuation and assessed by the investigators as at least possibly related to treatment (i.e., possibly, probably, definitely) were assessed. (NCT00283712)
Timeframe: Baseline to Week 26
| Intervention | Participants (Number) |
|---|---|
| Experimental: Infliximab (Remicade, Revellex) | 2 |
| Placebo Comparator: Placebo | 2 |
The Dermatology Life Quality Index (DLQI) is a 10-question questionnaire with a weighted value to each question. The DLQI score was calculated by summing the score of each question, resulting in a maximum score of 30 and a minimum score of 0. The higher the score, the greater quality of life is impaired. Change from baseline values (defined as the visit value - baseline value) were calculated. A negative change indicates better quality of life; a positive change indicates poorer quality of life. (NCT00283712)
Timeframe: Baseline to Week 18
| Intervention | units on a scale (Mean) |
|---|---|
| Experimental: Infliximab (Remicade, Revellex) | -2.0 |
| Placebo Comparator: Placebo | -4.0 |
Modified responder status was defined as participants achieving a prednisone dosage <=25% of the initial starting dose or <=10 mg/day (whichever is greater) at Week 18 regardless of status on new blister formation during the previous 4 weeks. (NCT00283712)
Timeframe: Baseline to Week 18
| Intervention | Participants (Number) |
|---|---|
| Experimental: Infliximab (Remicade, Revellex) | 5 |
| Placebo Comparator: Placebo | 3 |
Participants classified as responders at Week 18 had: 1. Achieved a prednisone dosage <= 25% of the initial starting dose or <= 10 mg/day (whichever is greater), and 2. Had no new blisters within the previous 4 weeks. (NCT00283712)
Timeframe: Baseline to Week 18
| Intervention | Participants (Number) |
|---|---|
| Experimental: Infliximab (Remicade, Revellex) | 1 |
| Placebo Comparator: Placebo | 1 |
Participants classified as responders at Week 18 had: 1. Achieved a prednisone dosage <= 25% of the initial starting dose or <=10 mg/day (whichever is greater), and 2. Had no new blisters within the previous 4 weeks. (NCT00283712)
Timeframe: Baseline to Week 18
| Intervention | Participants (Number) |
|---|---|
| Experimental: Infliximab (Remicade, Revellex) | 1 |
| Placebo Comparator: Placebo | 1 |
Time to cessation of new blisters was defined as the time from a participant's first treatment infusion date to the first date where that date and all subsequent dates had no new blisters. Participant diaries were used to assess new blister formation. To achieve cessation, participants had to be free of new blisters at least 3 weeks prior to their last assessment. In order to analyze missing or incomplete data, the data was censored at the date where a participant had no more data or on the date where 50% of the participant's data was missing past that point. (NCT00283712)
Timeframe: Baseline to Week 26
| Intervention | Days (Mean) |
|---|---|
| Experimental: Infliximab (Remicade, Revellex) | 133.0 |
| Placebo Comparator: Placebo | 98.0 |
Serious and life-threatening infections of Grade 3 or greater based on the National Cancer Institute (NCI), Common Terminology Criteria for Adverse Events (NCI-CTCAE), Version 3.0 were assessed. (NCT00283712)
Timeframe: Baseline to Week 26
| Intervention | Participants (Number) |
|---|---|
| Experimental: Infliximab (Remicade, Revellex) | 0 |
| Placebo Comparator: Placebo | 0 |
Participants who experienced severe infusion reactions of Grade 3 or greater based on the National Cancer Institute (NCI), Common Terminology Criteria for Adverse Events (NCI-CTCAE), Version 3.0 were assessed. (NCT00283712)
Timeframe: Baseline to Week 26
| Intervention | Participants (Number) |
|---|---|
| Experimental: Infliximab (Remicade, Revellex) | 0 |
| Placebo Comparator: Placebo | 0 |
Time to 80% healing of existing erosions/ulcerations at time of enrollment was assessed using the SAGE II computerized burn-mapping system. The date of 80% healing of existing erosions/ulcerations at time of enrollment was defined as follows: the first date at which the percent of total body surface area (BSA) involved is at least 80% less than the percent of total BSA calculated at the time of enrollment, where the baseline percent of total BSA must be greater than zero percent. If a participant had missing post-baseline assessments, their data was censored at their last non-missing assessment date. (NCT00283712)
Timeframe: Baseline to Week 26
| Intervention | Days (Mean) |
|---|---|
| Experimental: Infliximab (Remicade, Revellex) | 77.8 |
| Placebo Comparator: Placebo | 58.0 |
Each participant's prednisone dose was summed from the time of enrollment until the date of 80% healing of existing erosions. Actual prednisone use per day was computed as the average over all days in the week. (NCT00283712)
Timeframe: Baseline to Week 26
| Intervention | mg (Mean) |
|---|---|
| Experimental: Infliximab (Remicade, Revellex) | 2921.5 |
| Placebo Comparator: Placebo | 2958.8 |
Each participant's prednisone dose was summed from the time of enrollment until the date of cessation of new blisters. Actual prednisone use per day was computed as the average over all days in the week. (NCT00283712)
Timeframe: Baseline to Week 26
| Intervention | mg (Mean) |
|---|---|
| Experimental: Infliximab (Remicade, Revellex) | 4009.0 |
| Placebo Comparator: Placebo | 6446.7 |
"Grades were based on the National Cancer Institute (NCI), Common Terminology Criteria for Adverse Events (NCI-CTCAE), Version 3.0. An adverse event (AE) was considered treatment-related if it was classified as unlikely, possibly, probably, or definitely related to study treatment. Participants who experienced at least one treatment-related, grade 3 or higher AE were counted only once. AEs of skin including rash, skin ulceration, and chelitis as defined by the NCI-CTCAE V3.0 System Organ Class of Skin and Subcutaneous Tissues Disorders were excluded." (NCT00283712)
Timeframe: Baseline to Week 18
| Intervention | Participants (Number) |
|---|---|
| Experimental: Infliximab (Remicade, Revellex) | 0 |
| Placebo Comparator: Placebo | 10 |
The primary efficacy endpoint of response to treatment at Week 18 was reassessed at study weeks 22 and 26 for participants who were responders at Week 18. Participants classified as responders had: 1. Achieved a prednisone dosage <= 25% of the initial starting dose or <= 10 mg/day (whichever is greater), and 2. had no new blisters within the previous 4 weeks. (NCT00283712)
Timeframe: Baseline to Week 26
| Intervention | Participants (Number) | |
|---|---|---|
| Week 22 | Week 26 | |
| Experimental: Infliximab (Remicade, Revellex) | 1 | 1 |
| Placebo Comparator: Placebo | 0 | 0 |
The Medical Outcome Study Short Form 36 (MOS SF-36) measures health -related quality of life across multiple disease states. It has 36 questions with 8 subscale scores and 2 summary scores: PCS=physical functioning, role-physical, bodily pain, and general health; MCS=vitality, social functioning, role-emotional, and mental health. Scoring is done for both subscores and summary scores. For both, 0=worst score (or quality of life) and 100=best score. Change from baseline is computed as the value at Week 18 minus the baseline value. A positive value in change from Baseline indicates an improvement and a negative value worsening. (NCT00283712)
Timeframe: Baseline to Week 18
| Intervention | units on a scale (Mean) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Physical Functioning Scale | Role Functioning Scale | Bodily Pain Scale | General Health Scale | Physical Component Scale | Vitality Scale | Social Functioning Scale | Role Emotional Scale | Mental Health Scale | Mental Component Scale | |
| Experimental: Infliximab (Remicade, Revellex) | 4.0 | 0.3 | 3.7 | -0.8 | 2.2 | -1.6 | 0.0 | 1.2 | 1.4 | -0.5 |
| Placebo Comparator: Placebo | 4.0 | 6.3 | 3.2 | 3.6 | 3.5 | 1.7 | 3.0 | 4.8 | 6.6 | 4.4 |
The Pemphigus Vulgaris Disease Activity (PVDA) score was used to grade a participant's disease activity using the SAGE II computerized burn mapping system, which calculated the total body surface area (BSA) involved. Scores were based on the number of new lesions and blisters present, old lesion history and BSA involved. Scores range from 0 to 3 (none to severe disease activity). A new disease activity score of 3 or an old lesion score of 3 indicates active disease. New disease activity scores of 3 for a 1-month duration or an old lesion score of 3 for 2 consecutive months was cause for removal from the study treatment (NCT00283712)
Timeframe: Baseline to Week 26
| Intervention | Participants (Number) | |
|---|---|---|
| New Scores of 3 for a 1- Month Duration | Old Lesion Scores of 3 in 2 Consecutive Mos. | |
| Experimental: Infliximab (Remicade, Revellex) | 0 | 0 |
| Placebo Comparator: Placebo | 0 | 0 |
The duration of prednisone maintenance dosing was defined as the number of days that subjects maintained a prednisone dose of not more than 10 mg/day in the absence of new persistent lesions. (NCT00683930)
Timeframe: 52 weeks
| Intervention | Days (Median) |
|---|---|
| Placebo | 136.5 |
| MMF 2 g/Day and MMF 3 g/Day Groups Combined | 186.0 |
| Mycophenolate Mofetil 2 g/Day | 185.0 |
| Mycophenolate Mofetil 3 g/Day | 187.0 |
The proportion of subjects achieving responder status (defined as no new persistent lesions and prednisone dose of not more than 10 mg/day from Week 48 until study termination at Week 52) in the two active treatment groups combined (2 g/day and 3 g/day mycophenolate mofetil) compared with the placebo group (NCT00683930)
Timeframe: 52 weeks
| Intervention | Percentage of Participants (Number) |
|---|---|
| Placebo | 63.9 |
| MMF 2 g/Day and MMF 3 g/Day Groups Combined | 69.0 |
Time to initial response defined as the time that the subject first demonstrated responder status (defined as no new persistent lesions and prednisone dose of not more than 10 mg/day from Week 48 until study termination at Week 52) (NCT00683930)
Timeframe: up to 52 weeks
| Intervention | Weeks (Median) |
|---|---|
| Placebo | 31.3 |
| MMF 2 g/Day and MMF 3 g/Day Groups Combined | 24.1 |
Time to sustained response is defined as the week the subject first demonstrates both of the conditions of responder status provided the conditions are maintained through to study termination at Week 52. If a subject does not have a sustained response, time to sustained response is censored on the last day of the study. (NCT00683930)
Timeframe: up to 52 weeks
| Intervention | Weeks (Median) |
|---|---|
| Placebo | 46.0 |
| MMF 2 g/Day and MMF 3 g/Day Groups Combined | 32.1 |
35 reviews available for prednisone and Pemphigus Foliaceus
| Article | Year |
|---|---|
Rituximab: A Review in Pemphigus Vulgaris.
Topics: Drug Therapy, Combination; Glucocorticoids; Humans; Immunologic Factors; Pemphigus; Prednisone; Rand | 2020 |
Pulmonary nocardiosis in a patient with pemphigus foliaceus: case report and literature review.
Topics: Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Humans; Immunocompromised Host; Male; Middle Ag | 2021 |
[Cutaneous pemphigus vulgaris. A case report].
Topics: Adult; Biopsy; Glucocorticoids; Humans; Male; Pemphigus; Prednisone; Scalp Dermatoses | 2013 |
Pemphigus vulgaris in pregnancy: analysis of current data on the management and outcomes.
Topics: Adolescent; Adult; Azathioprine; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Infant, | 2009 |
Rituximab in childhood pemphigus vulgaris: a long-term follow-up case and review of the literature.
Topics: Adolescent; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Azathioprine; B-Lymphocytes; Chi | 2010 |
IgG/IgA pemphigus with IgG and IgA antidesmoglein 3 antibodies and IgA antidesmoglein 1 antibodies detected by enzyme-linked immunosorbent assay: a case report and review of the literature.
Topics: Adult; Autoantibodies; Blister; Desmoglein 1; Desmoglein 3; Diabetes Mellitus; Enzyme-Linked Immunos | 2010 |
Management of pemphigus in pediatric patients.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal, Murine-Derived; Child; Drug Therapy, Combination; H | 2011 |
[Pemphigus in children and adolescents].
Topics: Adolescent; Anti-Inflammatory Agents; Child; Humans; Pemphigus; Prednisone | 2004 |
Pemphigus vulgaris: a case-based update.
Topics: Aged; Anti-Inflammatory Agents; Beclomethasone; Diagnosis, Differential; Female; Fluorescent Antibod | 2005 |
Bullous pemphigoid and pemphigus vulgaris.
Topics: Antibody Specificity; Antigen-Antibody Reactions; Autoantibodies; Autoimmune Diseases; Bandages; Bas | 1983 |
[Pemphigus and pemphigoid].
Topics: Adult; Child, Preschool; Dermatitis Herpetiformis; Diagnosis, Differential; Female; Humans; Immunosu | 1980 |
Cyclosporine for the treatment of pemphigus vulgaris.
Topics: Autoimmune Diseases; Cyclosporine; Humans; Pemphigus; Prednisone; Remission Induction | 1994 |
Pemphigus erythematosus in a five-year-old child.
Topics: Administration, Oral; Child; Dapsone; Erythema; Female; Humans; Pemphigus; Prednisone | 1994 |
Pemphigus vulgaris in adolescence. A case presentation and review of the literature.
Topics: Adolescent; Female; Humans; Mouth Diseases; Pemphigus; Prednisone | 1994 |
Neonatal pemphigus vulgaris in a child born to a woman in remission.
Topics: Adult; Diagnosis, Differential; Female; Humans; Infant, Newborn; Pemphigus; Prednisone | 1993 |
Retroperitoneal reticulum cell sarcoma: a cause of paraneoplastic pemphigus.
Topics: Aged; Autoantibodies; Biopsy; Combined Modality Therapy; Cyclophosphamide; Cytoskeletal Proteins; De | 1993 |
Influence of treatment on the clinical course of pemphigus vulgaris.
Topics: Adjuvants, Pharmaceutic; Adult; Aged; Anti-Inflammatory Agents; Autoimmune Diseases; Contraindicatio | 1996 |
A case of pemphigus vulgaris with esophageal involvement.
Topics: Aged; Anti-Inflammatory Agents; Esophageal Diseases; Esophagoscopy; Female; Humans; Pemphigus; Predn | 1996 |
Paraneoplastic pemphigus.
Topics: Adult; Anti-Inflammatory Agents; Autoantigens; Autoimmune Diseases; Autoimmunity; Cell Adhesion Mole | 1997 |
Oral pemphigus vulgaris: a review of the literature and a report on the management of 12 cases.
Topics: Administration, Oral; Administration, Topical; Adolescent; Adult; Aged; Anti-Inflammatory Agents; Ch | 1997 |
A novel childhood pemphigus vegetans variant of intraepidermal neutrophilic IgA dermatosis.
Topics: Autoantibodies; Child; Cyclosporine; Humans; Immunoglobulin A; Immunosuppressive Agents; Liver Trans | 1998 |
Therapy of pemphigus vulgaris.
Topics: Humans; Immunosuppressive Agents; Mycophenolic Acid; Pemphigus; Prednisone | 1999 |
Mortality associated with concurrent strongyloidosis and cytomegalovirus infection in a patient on steroid therapy.
Topics: Anti-Inflammatory Agents; Cytomegalovirus Infections; Fatal Outcome; Humans; Immunocompromised Host; | 1999 |
Immunoablative high-dose cyclophosphamide without stem cell rescue in paraneoplastic pemphigus: report of a case and review of this new therapy for severe autoimmune disease.
Topics: Aged; Autoantibodies; Autoimmune Diseases; Cyclophosphamide; Cyclosporine; Follow-Up Studies; Glucoc | 1999 |
Pemphigus vulgaris in pregnancy: a case report and review of literature.
Topics: Adult; Amniocentesis; Female; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Pemphigus | 2000 |
Pemphigus vulgaris and disseminated nocardiosis.
Topics: Anti-Inflammatory Agents; Humans; Immunosuppressive Agents; Male; Middle Aged; Nocardia Infections; | 2000 |
Pemphigus and pemphigoid. A review of the advances made since 1964.
Topics: Acantholysis; Antibodies; Basement Membrane; Child; Complement System Proteins; Dermatitis Herpetifo | 1979 |
[Pemphigus vulgaris induced by radiotherapy].
Topics: Autoantibodies; Humans; Lymphoma; Male; Middle Aged; Pemphigus; Prednisone; Radiotherapy | 1991 |
Multiple dermatofibromas in patients with autoimmune disorders receiving immunosuppressive therapy.
Topics: Adolescent; Adult; Female; Fibroma; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Pemphi | 1991 |
Esophageal involvement in pemphigus vulgaris: report of two cases and review of the literature.
Topics: Aged; Complement C3; Endoscopy, Gastrointestinal; Esophageal Diseases; Female; Humans; Immunoglobuli | 1990 |
[A fatal case of pemphigus vulgaris with interstitial pneumonia occurring during gold therapy].
Topics: Azathioprine; Drug Therapy, Combination; Female; Gold Sodium Thiomalate; Humans; Middle Aged; Pemphi | 1989 |
Pemphigus and Kaposi's sarcoma.
Topics: Aged; Female; Humans; Immunosuppression Therapy; Pemphigus; Prednisone; Sarcoma, Kaposi | 1989 |
Disseminated superficial porokeratosis and immunosuppression.
Topics: Aged; Azathioprine; Drug Eruptions; Humans; Immunosuppression Therapy; Keratosis; Male; Pemphigus; P | 1988 |
[Dermatological news from America. I].
Topics: Acne Vulgaris; Adolescent; Adult; Aged; Anti-Bacterial Agents; Autoimmune Diseases; Blister; Child; | 1970 |
Immunosuppressants in the treatment of pemphigus.
Topics: Adult; Aged; Azathioprine; Drug Resistance, Microbial; Female; Humans; Infections; Male; Methotrexat | 1970 |
15 trials available for prednisone and Pemphigus Foliaceus
| Article | Year |
|---|---|
Treatment of pemphigus vulgaris and foliaceus with efgartigimod, a neonatal Fc receptor inhibitor: a phase II multicentre, open-label feasibility trial.
Topics: Antibodies, Monoclonal, Humanized; Autoantibodies; Desmoglein 1; Feasibility Studies; Histocompatibi | 2022 |
Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid-sparing effect.
Topics: Humans; Immunologic Factors; Immunosuppressive Agents; Pemphigus; Prednisone; Rituximab; Treatment O | 2020 |
Comparison of real costs in the French healthcare system in newly diagnosed patients with pemphigus for first-line treatment with rituximab vs. standard corticosteroid regimen: data from a national multicentre trial.
Topics: Adrenal Cortex Hormones; Delivery of Health Care; Humans; Pemphigus; Prednisone; Rituximab | 2020 |
Factors Associated With Short-term Relapse in Patients With Pemphigus Who Receive Rituximab as First-line Therapy: A Post Hoc Analysis of a Randomized Clinical Trial.
Topics: Adult; Aged; Autoantibodies; Desmoglein 3; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immuno | 2020 |
Proof of concept for the clinical effects of oral rilzabrutinib, the first Bruton tyrosine kinase inhibitor for pemphigus vulgaris: the phase II BELIEVE study.
Topics: Agammaglobulinaemia Tyrosine Kinase; Autoantibodies; Humans; Pemphigus; Prednisone; Protein Kinase I | 2021 |
A multicentre randomized trial of the treatment of patients with pemphigus vulgaris with infliximab and prednisone compared with prednisone alone.
Topics: Adult; Dermatologic Agents; Desmoglein 1; Desmoglein 3; Drug Therapy, Combination; Female; Humans; I | 2015 |
Treating pemphigus vulgaris with prednisone and mycophenolate mofetil: a multicenter, randomized, placebo-controlled trial.
Topics: Administration, Oral; Adult; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppr | 2010 |
Pemphigus vulgaris with oral involvement: evaluation of two different systemic corticosteroid therapeutic protocols.
Topics: Administration, Oral; Adult; Betamethasone; Biopsy, Needle; Dose-Response Relationship, Drug; Drug A | 2002 |
A single cycle of rituximab for the treatment of severe pemphigus.
Topics: Aged; Anti-Inflammatory Agents; Antibodies; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-D | 2007 |
Multicenter randomized, double-blind, placebo-controlled, clinical trial of dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Cross-Over | 2008 |
Steroid-pulse therapy in pemphigus vulgaris long term follow-up.
Topics: Administration, Oral; Adolescent; Adult; Autoantibodies; Azathioprine; Cyclophosphamide; Drug Therap | 1995 |
Treatment of oral pemphigus vulgaris.
Topics: Adult; Aged; Cyclophosphamide; Cyclosporine; Drug Combinations; Female; Fluorescent Antibody Techniq | 1994 |
Pemphigus vulgaris: benefits of tetracycline as adjuvant therapy in a series of thirteen patients.
Topics: Adult; Anti-Bacterial Agents; Azathioprine; Chemotherapy, Adjuvant; Drug Therapy, Combination; Femal | 1999 |
Effect of plasmapheresis therapy on circulating levels of pemphigus antibodies.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Antibodies; Azathioprine; Cyclophosphamide; | 1990 |
[Treatment of pemphigus].
Topics: Adult; Antimetabolites, Antineoplastic; Azathioprine; Clinical Trials as Topic; Drug Evaluation; Dru | 1974 |
347 other studies available for prednisone and Pemphigus Foliaceus
| Article | Year |
|---|---|
Dexamethasone or prednisone: Which one should be the corticosteroid of choice in patients with pemphigus vulgaris?
Topics: Adrenal Cortex Hormones; Dexamethasone; Glucocorticoids; Humans; Pemphigus; Prednisone | 2022 |
Assessing the use of methotrexate as an alternate therapy for pemphigus vulgaris and pemphigus foliaceus.
Topics: Glucocorticoids; Humans; Methotrexate; Pemphigus; Prednisone; Remission Induction; Retrospective Stu | 2022 |
Pemphigus vulgaris after the second dose of COVID-19 vaccination: a case report.
Topics: Autoimmune Diseases; COVID-19; COVID-19 Vaccines; Female; Humans; Middle Aged; Pemphigus; Prednisone | 2023 |
Pemphigus vegetans with isolated involvement of the nose and chest: rare variant of pemphigus vulgaris.
Topics: Aged, 80 and over; Biopsy; Glucocorticoids; Humans; Male; Nose; Pemphigus; Prednisone; Skin; Thorax; | 2019 |
Results of the guideline-based treatment for pemphigus: a single-centre experience with 84 cases.
Topics: Aged; Azathioprine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Pemphigus; Predniso | 2020 |
Pruritic Blistering Eruption: Answer.
Topics: Anti-Inflammatory Agents; Autoantibodies; Autoantigens; Dermatitis Herpetiformis; Desmoglein 1; Fema | 2020 |
Acute generalized exanthematous pustulosis induced by Mycophenolate Mofetil: A case complicated with pemphigus foliaceus.
Topics: Acute Generalized Exanthematous Pustulosis; Female; Humans; Middle Aged; Mycophenolic Acid; Pemphigu | 2020 |
Ultra-low dose rituximab for refractory pemghigus vulgaris: a pilot study.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antineoplastic Agents, Immunological; Autoantibodies; Desmogl | 2020 |
Pemphigus vegetans with paronychia-like changes resistant to rituximab therapy.
Topics: Humans; Organic Chemicals; Paronychia; Pemphigus; Prednisone; Rituximab | 2020 |
Correlation of IgG autoantibodies against acetylcholine receptors and desmogleins in patients with pemphigus treated with steroid sparing agents or rituximab.
Topics: Adult; Aged; Autoantibodies; Autoantigens; Desmoglein 1; Desmoglein 3; Female; Humans; Immunoglobuli | 2020 |
Aggressive refractory pemphigus vulgaris that responded to plasmapheresis: a case report.
Topics: Adolescent; Aged; Child; Female; Humans; Middle Aged; Pemphigus; Plasma Exchange; Plasmapheresis; Pr | 2020 |
Complete remission of refractory pemphigus vulgaris in a Chinese patient with mutated NUDT15 by combination of minimal doses of azathioprine and prednisone.
Topics: Asian People; Azathioprine; China; Humans; Male; Pemphigus; Prednisone | 2020 |
Treatment of Pemphigus Vulgaris and Foliaceus with Adjuvant Rituximab Compared to Immunosuppression Alone: Real-Life Experience.
Topics: Adult; Azathioprine; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Midd | 2021 |
Short-Term Intravenous Infusion of Cyclophosphamide in the Treatment of Refractory Pemphigus Vulgaris: A Retrospective Study.
Topics: Adolescent; Adult; Aged; Autoantibodies; Cyclophosphamide; Desmoglein 1; Desmoglein 3; Drug Resistan | 2021 |
Thalidomide as a potential adjuvant treatment for paraneoplastic pemphigus: A single-center experience.
Topics: Humans; Neoplasm Recurrence, Local; Paraneoplastic Syndromes; Pemphigus; Prednisone; Thalidomide | 2020 |
Chronic lymphocytic leukemia-associated paraneoplastic pemphigus: potential cause and therapeutic strategies.
Topics: Adult; Aged, 80 and over; Antineoplastic Agents; Female; Humans; Leukemia, Lymphocytic, Chronic, B-C | 2020 |
Hallopeau type of pemphigus vegetans, an unusual clinical presentation of an infrequent disease.
Topics: Adult; Axilla; Diagnosis, Differential; Female; Glucocorticoids; Humans; Mouth Mucosa; Pemphigus; Pr | 2020 |
[Pemphigus: Towards a drastic reduction in corticosteroid therapy thanks to rituximab].
Topics: Adrenal Cortex Hormones; Humans; Immunologic Factors; Pemphigus; Prednisone; Prospective Studies; Ri | 2017 |
Using immune checkpoint inhibitors without exacerbation in a melanoma patient with pemphigus foliaceus.
Topics: Aged; Anti-Inflammatory Agents; Antineoplastic Agents, Immunological; Fatal Outcome; Female; Humans; | 2017 |
Achievement of the longest survival of paraneoplastic pemphigus with bronchiolitis obliterans associated with follicular lymphoma using R-CHOP chemotherapy.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bronchioliti | 2017 |
Rituximab in pemphigus.
Topics: Autoantibodies; B-Lymphocytes; Clinical Trials as Topic; Desmogleins; Drug Therapy, Combination; Hum | 2018 |
Acute Flare of Bullous Pemphigus With Pembrolizumab Used for Treatment of Metastatic Urothelial Cancer.
Topics: Acute Disease; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Disease Prog | 2018 |
Rituximab and short-course prednisone as the new gold standard for new-onset pemphigus vulgaris and pemphigus foliaceus.
Topics: Humans; Pemphigus; Prednisone; Rituximab | 2017 |
Pemphigus foliaceus with pustular presentation in a patient with psoriasis.
Topics: Biopsy; Dose-Response Relationship, Drug; Erythema; Glucocorticoids; Humans; Male; Middle Aged; Pemp | 2017 |
Reduced IgG anti-desmocollin autoantibody titre and concomitant improvement in a patient with pemphigus vegetans.
Topics: Aged, 80 and over; Antibodies, Anti-Idiotypic; Biomarkers; Biopsy, Needle; Dermoscopy; Desmocollins; | 2018 |
Pemphigus foliaceus induced by topical imiquimod treatment.
Topics: Adjuvants, Immunologic; Administration, Oral; Administration, Topical; Anti-Inflammatory Agents; Com | 2018 |
A rare cause of unilateral facial rash.
Topics: Facial Dermatoses; Female; Fluorescent Antibody Technique, Direct; Humans; Immunosuppressive Agents; | 2019 |
Comparison of rituximab and conventional adjuvant therapy for pemphigus vulgaris: A retrospective analysis.
Topics: Adjuvants, Immunologic; Aged; Case-Control Studies; Female; Glucocorticoids; Humans; Male; Middle Ag | 2018 |
Painful ulceration of the vulva.
Topics: Adult; Azathioprine; Female; Gingival Diseases; Glucocorticoids; Humans; Immunologic Factors; Pemphi | 2019 |
New onset bullae in a pregnant woman.
Topics: Adult; Biopsy; Female; Glucocorticoids; Humans; Methylprednisolone; Pemphigus; Prednisone; Pregnancy | 2020 |
Pemphigus vegetans of the tongue: a diagnostic and therapeutic challenge.
Topics: Aged; Anti-Infective Agents; Dapsone; Female; Glucocorticoids; Humans; Pemphigus; Prednisone; Tongue | 2013 |
Adjuvant rituximab therapy in pemphigus: a single-center experience of 18 cases.
Topics: Adrenal Cortex Hormones; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Chemotherapy, Adjuvant | 2013 |
Assessment of the rate of long-term complete remission off therapy in patients with pemphigus treated with different regimens including medium- and high-dose corticosteroids.
Topics: Adrenal Cortex Hormones; Adult; Aged; Cohort Studies; Disease Progression; Dose-Response Relationshi | 2013 |
[Transition from pemphigus vulgaris to pemphigus foliaceus: a case report].
Topics: Antibodies, Monoclonal, Murine-Derived; Autoantibodies; Autoantigens; Desmoglein 1; Desmoglein 3; Di | 2013 |
IgA pemphigus: case series with emphasis on therapeutic response.
Topics: Acitretin; Adalimumab; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Antib | 2014 |
Opportunistic infections in patients with pemphigus.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Azathioprine; Cytomegalovirus | 2014 |
Pemphigus foliaceus in an adolescent.
Topics: Adolescent; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Mycophenolic Acid; Pemphigus; | 2014 |
Pemphigus vulgaris in pregnancy.
Topics: Adult; Anti-Inflammatory Agents; Biopsy; Dose-Response Relationship, Drug; Female; Fluorescent Antib | 2014 |
Pathology in practice. Pemphigus vulgaris.
Topics: Animals; Anti-Ulcer Agents; Chlorhexidine; Dog Diseases; Dogs; Female; Foot; Mouth; Pemphigus; Predn | 2015 |
Elevated interleukin-33 and soluble ST2 levels in the sera of patients with pemphigus vulgaris: correlation with clinical and immunological parameters during follow-up.
Topics: Case-Control Studies; Dermatologic Agents; Desmoglein 3; Female; Follow-Up Studies; Glucocorticoids; | 2015 |
Usefulness of specific anti-desmoglein 1 and 3 enzyme-linked immunoassay and indirect immunofluorescence in the evaluation of pemphigus activity.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antibodies; Desmoglein 1; Desmoglein 3; En | 2015 |
To (anti-)TNF or not (anti-)TNF? That is the question in pemphigus.
Topics: Dermatologic Agents; Female; Humans; Infliximab; Male; Pemphigus; Prednisone | 2015 |
Successful treatment of oral pemphigus vulgaris in an insulin-dependant geriatric patient.
Topics: Biopsy; Clobetasol; Female; Humans; Pemphigus; Prednisone | 2016 |
Yearly reduction of glucocorticoid dose by 50% as tapering schedule achieves complete remission for 124 pemphigus vulgaris patients.
Topics: Adult; Aged; Drug Administration Schedule; Female; Glucocorticoids; Humans; Male; Middle Aged; Pemph | 2016 |
IVIG therapy in pemphigus vulgaris has corticosteroid-sparing and immunomodulatory effects.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Female; Humans; Immunoglobulins, Intravenous; Immunomod | 2016 |
Extensive keloid formation after pemphigus vulgaris.
Topics: Adrenal Cortex Hormones; Aged; Dermatologic Agents; Drug Therapy, Combination; Humans; Keloid; Male; | 2015 |
Epidemiological data of 290 pemphigus vulgaris patients: a 29-year retrospective study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Child; Comorbidity; Female; Hu | 2016 |
Unusual Histological Evidence of Dysplasia in a Case of Oral Pemphigus Vulgaris: A Potential Diagnostic Challenge.
Topics: Aged; Anti-Inflammatory Agents; Azathioprine; Drug Therapy, Combination; Humans; Immunosuppressive A | 2016 |
Pemphigus Herpetiformis With Autoantibodies to Desmoglein 1 and 3.
Topics: Adult; Autoantibodies; Autoantigens; Dapsone; Dermatitis Herpetiformis; Desmoglein 1; Desmoglein 3; | 2016 |
Efficacy of Dapsone in the Treatment of Pemphigus Vulgaris: A Single-Center Case Study.
Topics: Adult; Aged; Anti-Infective Agents; Anti-Inflammatory Agents; Dapsone; Drug Therapy, Combination; Fe | 2016 |
Do safe and effective treatment options exist for patients with active pemphigus vulgaris who plan conception and pregnancy?
Topics: Administration, Oral; Adult; Anti-Infective Agents; Dapsone; Dose-Response Relationship, Drug; Drug | 2008 |
Contact pemphigus: a side-effect of imiquimod therapy.
Topics: Administration, Topical; Aminoquinolines; Azathioprine; Biopsy, Needle; Dose-Response Relationship, | 2008 |
Paraneoplastic pemphigus associated with non-Hodgkin lymphoma.
Topics: Acantholysis; Animals; Antineoplastic Combined Chemotherapy Protocols; Back; Cyclophosphamide; Doxor | 2008 |
Rituximab in refractory pemphigus vulgaris.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD19; Antigens, CD2 | 2008 |
Development of pemphigus vulgaris in a patient with psoriasis treated with etanercept.
Topics: Etanercept; Humans; Immunoglobulin G; Male; Methotrexate; Middle Aged; Pemphigus; Phototherapy; Pred | 2009 |
[Pemphigus vegetans].
Topics: Aged; Anti-Inflammatory Agents; Diagnosis, Differential; Humans; Male; Pemphigus; Prednisone; Skin | 2008 |
Hallopeau type of pemphigus vegetans confined to the right foot: case report.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Female; Foot Diseases; Humans; Middle Aged; Neomyci | 2009 |
Impact of oral lesions on diagnosis, treatment and prognosis of pemphigus.
Topics: Adult; Aged; Female; Humans; Male; Middle Aged; Mouth Diseases; Pemphigus; Prednisone; Prognosis | 2009 |
ELISA testing of anti-desmoglein 1 and 3 antibodies in the management of pemphigus.
Topics: Antibodies; Desmoglein 1; Desmoglein 2; Disease Progression; Drug Therapy, Combination; Enzyme-Linke | 2009 |
Paraneoplastic pemphigus associated with systemic mastocytosis.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Cladribine; Disease Progres | 2009 |
Successful treatment of pemphigus vulgaris with etanercept in four patients.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Dose-Response Relationship, Drug; Etanercept; Female | 2009 |
A case of bullous disease limited to the skin illustrates the spectrum of neoplasia-induced autoimmunity.
Topics: Aged, 80 and over; Antibodies, Antinuclear; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-D | 2009 |
Paraneoplastic pemphigus associated with malignant gastrointestinal stromal tumour.
Topics: Adrenal Cortex Hormones; Autoantibodies; Digestive System Surgical Procedures; Dyspnea; Fatal Outcom | 2010 |
Pemphigus vulgaris--still a difficult disease to treat.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Azathi | 2010 |
High dose oral prednisone vs. prednisone plus azathioprine for the treatment of oral pemphigus: a retrospective, bi-centre, comparative study.
Topics: Administration, Oral; Adult; Aged; Anti-Inflammatory Agents; Azathioprine; Dose-Response Relationshi | 2011 |
Enteric-coated mycophenolate sodium in the treatment of refractory pemphigus.
Topics: Administration, Oral; Adult; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; | 2010 |
Therapeutic ladder for pemphigus vulgaris: emphasis on achieving complete remission.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Combined Modality Therapy; Female; Humans; Male | 2011 |
Letter: Pemphigus herpetiformis of age of onset at 6 years.
Topics: Child; Dapsone; Dermatitis Herpetiformis; Dermatologic Agents; Female; Humans; Pemphigus; Prednisone | 2011 |
Blistering eruption on the leg of an adult.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Blister; Ciprofloxacin; Dermatitis Herpetiformis; D | 2011 |
The impact of stratifying initial dose of corticosteroids by severity of pemphigus vulgaris on long-term disease severity.
Topics: Adult; Age of Onset; Aged; Databases, Factual; Drug Administration Schedule; Female; Follow-Up Studi | 2011 |
Pemphigus vulgaris in three adolescents: the course of the disease.
Topics: Adolescent; Azathioprine; Dapsone; Dexamethasone; Drug Therapy, Combination; Female; Glucocorticoids | 2011 |
An unusual case of annular bollous eruption of the inguinal folds.
Topics: Abdomen; Acantholysis; Adult; Anti-Inflammatory Agents; Axilla; Dermatitis Herpetiformis; Diagnosis, | 2011 |
[Follicular lymphoma with paraneoplastic autoimmune multiorgan syndrome].
Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Autoim | 2012 |
Rituximab used as a first-line single agent in the treatment of pemphigus vulgaris.
Topics: Acetaminophen; Antibodies, Monoclonal, Murine-Derived; Chlorpheniramine; Drug Therapy, Combination; | 2011 |
Pneumocystis pneumonia in patients with immunobullous dermatoses.
Topics: Aged; Female; Glucocorticoids; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middl | 2011 |
The course and prognosis of pemphigus in 47 Tunisian patients.
Topics: Administration, Oral; Adult; Age Distribution; Aged; Aged, 80 and over; Cohort Studies; Confidence I | 2013 |
[A case of disseminated cryptococcosis complicating treatment of pemphigus vulgaris with prednisone and azathioprime].
Topics: Aged; Azathioprine; Cryptococcosis; Fatal Outcome; Female; Glucocorticoids; Humans; Immunosuppressiv | 2011 |
Therapy with rituximab for autoimmune pemphigus: results from a single-center observational study on 42 cases with long-term follow-up.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Drug Therapy, Combination; Female; Follow-Up St | 2012 |
Pemphigus vegetans of the nose.
Topics: Adult; Female; Glucocorticoids; Humans; Nose Diseases; Pemphigus; Prednisone | 2012 |
Effect of a single-cycle alternative dosing regimen for rituximab for recalcitrant pemphigus: a case series of 9 patients.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Dose-Response Relationship, Drug; Drug Administration | 2012 |
Low-level laser therapy on the treatment of oral and cutaneous pemphigus vulgaris: case report.
Topics: Adult; Humans; Immunosuppressive Agents; Low-Level Light Therapy; Male; Middle Aged; Mouth Diseases; | 2012 |
Pemphigus vulgaris--a report of three cases.
Topics: Absorptiometry, Photon; Adult; Antimetabolites; Azathioprine; Diagnosis, Differential; Endoscopy; Fe | 2012 |
Neonatal pemphigus foliaceus.
Topics: Adult; Female; Humans; Infant, Newborn; Maternal-Fetal Exchange; Pemphigus; Prednisone; Pregnancy; P | 2012 |
Varicella-zoster virus (VZV) and alpha 1 antitrypsin: a fatal outcome in a patient affected by endemic pemphigus foliaceus.
Topics: Acyclovir; Adult; alpha 1-Antitrypsin; Antiviral Agents; Azathioprine; Chickenpox; Endemic Diseases; | 2012 |
Cryptic esophageal pemphigus vulgaris despite apparent clinical remission.
Topics: Esophageal Diseases; Glucocorticoids; Humans; Male; Middle Aged; Pemphigus; Prednisone | 2012 |
Is it time to re-evaluate the treatment of pemphigus?
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal, Murine-Derived; Humans; Immunoglobulins, Intraveno | 2012 |
Mycophenolate mofetil as a first-line steroid-sparing agent in the treatment of pemphigus vulgaris.
Topics: Anti-Inflammatory Agents; Burn Units; Dermatologic Agents; Hospitalization; Humans; Male; Middle Age | 2013 |
[Pemphigus vulgaris: an unusual clinical presentation].
Topics: Acantholysis; Facial Dermatoses; Fluorescent Antibody Technique, Direct; Foot Dermatoses; Humans; Im | 2013 |
Corticosteroid-sparing effect of intravenous immunoglobulin therapy in patients with pemphigus vulgaris.
Topics: Adult; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug | 2002 |
A patient with immunological features of paraneoplastic pemphigus in the absence of a detectable malignancy.
Topics: Aged; Autoantibodies; Autoantigens; Azathioprine; Cytoskeletal Proteins; Desmoplakins; Disease Progr | 2002 |
Pemphigus vulgaris: a review of treatment over a 19-year period.
Topics: Adrenal Cortex Hormones; Croatia; Female; Fluorescent Antibody Technique; Humans; Immunosuppressive | 2002 |
[Treatment of pemphigus vulgaris by azathioprine and low doses of prednisone (Lever scheme)].
Topics: Adult; Aged; Aged, 80 and over; Azathioprine; Drug Therapy, Combination; Female; Glucocorticoids; Hu | 2003 |
Plasmapheresis therapy in pemphigus vulgaris and bullous pemphigoid.
Topics: Aged; Combined Modality Therapy; Disease Management; Female; Humans; Immunosuppressive Agents; Male; | 2003 |
Disseminated cellulitic cryptococcosis in the setting of prednisone monotherapy for pemphigus vulgaris.
Topics: Antifungal Agents; Cellulitis; Cryptococcosis; Diabetes Mellitus, Type 2; Diagnosis, Differential; D | 2003 |
Evaluating the role of immunoablative high-dose cyclophosphamide therapy in pemphigus vulgaris.
Topics: Adult; Algorithms; Antibodies; Cadherins; Cyclophosphamide; Desmoglein 3; Female; Humans; Immunosupp | 2003 |
Pemphigus vulgaris: the eyes have it.
Topics: Adolescent; Autoimmune Diseases; Biopsy; Conjunctivitis; Corneal Ulcer; Deglutition Disorders; Diagn | 2003 |
Successful treatment of B cell chronic lymphocytic leukemia-associated severe paraneoplastic pemphigus with cyclosporin A.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Combined Modality Therapy; Cyclophosph | 2003 |
[Use of a new cortisone-like steroid, prednisone, in therapy of pemphigus and other dermatoses].
Topics: Cortisone; Humans; Pemphigus; Prednisone; Skin Diseases; Steroids | 1955 |
[Cortical steroids in dermatology. II. New derivatives of adrenal cortex hormones in therapy of pemphigus and Duhring's dermatitis].
Topics: Adrenal Cortex Hormones; Dermatitis; Dermatitis Herpetiformis; Dermatology; Humans; Pemphigus; Predn | 1957 |
[Pemphigus; large doses of cortisone in therapy].
Topics: Cortisone; Pemphigus; Prednisone | 1958 |
On Therapy of Pemphigus vegetans.
Topics: Humans; Pemphigus; Prednisone | 1958 |
[Treatment of pemphigus vulgaris with massive doses of meticorten].
Topics: Humans; Pemphigus; Prednisone | 1959 |
[Observations & remarks on hormone treatment with prednisone & ACTH in cases of pemphigus].
Topics: Adrenocorticotropic Hormone; Pemphigus; Prednisone | 1959 |
Ulcerative colitis arising during corticosteroid therapy: report of a case.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Colitis; Colitis, Ulcerative; Humans; Pemphigu | 1960 |
[Experiences with ambulant steroid follow-up treatment in pemphigus].
Topics: Adrenocorticotropic Hormone; Follow-Up Studies; Pemphigus; Prednisolone; Prednisone | 1962 |
Treatment of pemphigus with corticosteroids. Results obtained in 46 patients over a period of 11 years.
Topics: Adrenal Cortex Hormones; Antacids; Cortisone; Dermatologic Agents; Diethylstilbestrol; Estrogens, Co | 1963 |
[On the possible therapeutic utility of the association of lysozyme and corticoids in dermatology. Preliminary clinical contribution].
Topics: Adrenal Cortex Hormones; Dermatitis; Dermatitis Herpetiformis; Dermatitis, Exfoliative; Dermatologic | 1963 |
[ERYTHRODERMAL AND PROGRESSIVE VERRUCOUS STAGE OF PEMPHIGUS FOLIACEUS. SIMILARITY OF THESE CLINICAL PICTURES WITH THEIR HOMOLOGUES PRESENTED BY BRAZILIAN FOGO SELVAGEM. THERAPEUTIC TRIAL OF JAMARSAN].
Topics: Betamethasone; Borates; Brazil; Calcium; Coal Tar; Humans; Oils; Pemphigus; Prednisone; Sulfur; Tria | 1963 |
PEMPHIGUS VEGETANS. REPORT OF AN UNUSUAL CASE.
Topics: Diagnosis; Gingivitis; Humans; Liver Diseases; Mucous Membrane; Organic Chemicals; Pathology; Pemphi | 1963 |
[GENERAL CORTICOTHERAPY IN DERMATOLOGY].
Topics: Adrenal Cortex Hormones; Cortisone; Dermatitis Herpetiformis; Dermatology; Dermatomyositis; Dexameth | 1963 |
[EFFICACY OF PREDNISONE CURE IN A CASE OF ATRIAL FIBRILLATION DURING THE COURSE OF PEMPHIGUS AND ITS POSSIBLE SIGNIFICANCE].
Topics: Atrial Fibrillation; Cardiovascular Diseases; Digitalis Glycosides; Humans; Pemphigus; Prednisone | 1964 |
[PEMPHIGOID. ITS RELATIONSHIP WITH OTHER BULLOUS ERUPTIONS].
Topics: Dermatitis Herpetiformis; Dermatology; Diagnosis, Differential; Erythema Multiforme; Geriatrics; Hum | 1964 |
[CLINICAL ASPECTS AND THERAPY OF STEROID DIABETES].
Topics: Adrenal Cortex Hormones; Adrenal Gland Neoplasms; Adrenocorticotropic Hormone; Arthritis; Arthritis, | 1964 |
[RESULTS OF CORTICOID THERAPY IN CHRONIC PEMPHIGUS].
Topics: Adrenal Cortex Hormones; Geriatrics; Pemphigus; Prednisone; Toxicology | 1964 |
AVASCULAR BONE NECROSIS, A COMPLICATION OF LONG-TERM CORTICOSTEROID THERAPY.
Topics: Adrenal Cortex Hormones; Bone Diseases; Drug Therapy; Femur Head; Humans; Humerus; Joint Diseases; N | 1965 |
PEMPHIQUS VULGARIS COMPLICATED BY PREGNANCY.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Drug Therapy; Female; Fetal Death; Humans; Inf | 1965 |
ORAL SURGERY--ORAL PATHOLOGY CONFERENCE NO. 14, WALTER REED ARMY MEDICAL CENTER.
Topics: Adolescent; Conjunctiva; Diagnosis; Drug Therapy; Eye Diseases; Gingival Diseases; Humans; Mouth Muc | 1965 |
Pemphigus vulgaris treated with metacortandracin; case report.
Topics: Humans; Pemphigus; Prednisone; Steroids | 1955 |
[Steroid therapy of pemphigus associated with diabetes mellitus].
Topics: Diabetes Complications; Diabetes Mellitus; Humans; Pemphigus; Prednisone | 1961 |
Images in pathology: birefringent cryptococcus.
Topics: Amphotericin B; Anti-Inflammatory Agents; Antifungal Agents; Birefringence; Cellulitis; Cryptococcos | 2003 |
Desquamative gingivitis: early presenting symptom of mucocutaneous disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Autoimmune Diseases; Biopsy; Clobetasol; Dapsone; Diagnosis | 2003 |
Development of pemphigus herpetiformis in a patient with psoriasis receiving UV-light treatment.
Topics: Adult; Female; Humans; Pemphigus; Prednisone; Psoriasis; Skin; Treatment Outcome; Ultraviolet Therap | 2004 |
Juvenile pemphigus vegetans of the glans penis.
Topics: Adolescent; Biopsy, Needle; Humans; Immunohistochemistry; Male; Mouth Diseases; Mouth Mucosa; Pemphi | 2004 |
Pemphigus vulgaris with involvement of the cervix treated using thalidomide therapy.
Topics: Azathioprine; Diagnosis, Differential; Drug Administration Schedule; Drug Therapy, Combination; Fema | 2004 |
Rupturing bullae not responding to antibiotics.
Topics: Adult; Female; Glucocorticoids; Humans; Pemphigus; Prednisone | 2004 |
Dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris.
Topics: Adult; Aged; Biopsy, Needle; Dapsone; Dose-Response Relationship, Drug; Drug Administration Schedule | 2005 |
[Conjunctival blistering associated with pemphigus vulgaris: report of a case].
Topics: Aged; Autoantibodies; Autoimmune Diseases; Biopsy; Blister; Conjunctiva; Conjunctival Diseases; Fluo | 2005 |
Paraneoplastic pemphigus associated with non-Hodgkin B-cell lymphoma and good response to prednisone.
Topics: Aged; Diagnosis, Differential; Drug Administration Schedule; Female; Glucocorticoids; Humans; Lympho | 2005 |
[Treatment of juvenile pemphigus vulgaris with intravenous immunoglobulins].
Topics: Adolescent; Azathioprine; Drug Administration Schedule; Drug Therapy, Combination; Female; Glucocort | 2005 |
Localized Kaposi's sarcoma in a patient with pemphigus vulgaris.
Topics: Aged; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Male; Mycophenolic Acid; Pemphigu | 2006 |
Pemphigus foliaceous in a child.
Topics: Back; Child; Facial Dermatoses; Female; Glucocorticoids; Humans; Methylprednisolone; Pemphigus; Pred | 2006 |
[Tunisian erythematosus pemphigus associated with psoriasis in two sisters].
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Biopsy; Female; Fluorescent Antibody Techn | 2006 |
Images in emergency medicine. Pemphigus vulgaris.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; | 2006 |
Diagnostic dermatology.
Topics: Animals; Anti-Inflammatory Agents; Dermatitis; Dog Diseases; Dogs; Male; Otitis Externa; Pemphigus; | 2006 |
The role of IVIg treatment in severe pemphigus vulgaris.
Topics: Adult; Aged; Female; Humans; Immunoglobulins, Intravenous; Male; Middle Aged; Pemphigus; Prednisone; | 2006 |
Lichenoid paraneoplastic pemphigus in the absence of detectable antibodies.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antibody Formation; Antineopla | 2007 |
[Pemphigus: treatment and outcome in 122 cases].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents, Local; Chlorhexidine; Female; Glu | 2006 |
Efficacy and safety of cyclophosphamide, azathioprine, and cyclosporine (ciclosporin) as adjuvant drugs in pemphigus vulgaris.
Topics: Adolescent; Adult; Aged; Azathioprine; Child; Cyclophosphamide; Cyclosporine; Drug Therapy, Combinat | 2007 |
Cutaneous pemphigus vulgaris.
Topics: Anti-Inflammatory Agents; Cyclophosphamide; Dapsone; Diagnosis, Differential; Drug Therapy, Combinat | 2007 |
Red blood cell anemia in a patient with pemphigus vulgaris induced by the use of mycophenolate mofetil and prednisone.
Topics: Anemia; Drug Therapy, Combination; Erythrocyte Count; Female; Humans; Immunosuppressive Agents; Midd | 2007 |
Pemphigus vulgaris and pemphigus foliaceus: similar prognosis?
Topics: Adult; Aged; Autoantibodies; Desmoglein 1; Desmoglein 3; Female; Fluorescent Antibody Technique, Dir | 2007 |
Immunoglobulin A pemphigus involving the perianal skin and oral mucosa: an unusual presentation.
Topics: Anti-Infective Agents; Anus Diseases; Autoantigens; Dapsone; Female; Glucocorticoids; Humans; Immuno | 2007 |
An alternate-day corticosteroid regimen for pemphigus vulgaris. A 13-year prospective study.
Topics: Administration, Oral; Adult; Aged; Azathioprine; Chi-Square Distribution; Drug Administration Schedu | 2007 |
Treatment of pemphigus: the need for more evidence.
Topics: Dapsone; Drug Therapy, Combination; Humans; Needs Assessment; Pemphigus; Prednisone; Prognosis; Rand | 2008 |
Polymyositis and pemphigus vulgaris in a patient: successful treatment with rituximab.
Topics: Amyloidosis; Antibodies, Antinuclear; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived | 2008 |
Kinetics of response to conventional treatment in patients with pemphigus vulgaris.
Topics: Dose-Response Relationship, Drug; Glucocorticoids; Humans; Pemphigus; Prednisone; Retrospective Stud | 2008 |
Kaposi's varicelliform eruption complicating pemphigus foliaceus.
Topics: Adult; Female; Humans; Kaposi Varicelliform Eruption; Pemphigus; Prednisone | 1967 |
Pemphigus benignus familiaris (with special reference to the histopathological diagnosis).
Topics: Betamethasone; Female; Humans; Male; Middle Aged; Pemphigus; Prednisone; Triamcinolone | 1967 |
Pemphigus vulgaris and pulmonary nocardiosis.
Topics: Adult; Female; Humans; Lung Diseases, Fungal; Nocardia Infections; Pemphigus; Prednisone; Sulfisoxaz | 1967 |
Pemphigus: an epidemiological study of patients treated in Finnish hospitals between 1969 and 1978.
Topics: Adolescent; Adult; Age Factors; Aged; Child; Female; Finland; Humans; Male; Middle Aged; Pemphigus; | 1982 |
Juvenile pemphigus.
Topics: Adolescent; Adrenocorticotropic Hormone; Age Factors; Azathioprine; Child; Child, Preschool; Cortiso | 1983 |
Transient acantholytic dermatosis associated with pemphigus foliaceus. Coexistence of two acantholytic diseases.
Topics: Acantholysis; Administration, Topical; Aged; Humans; Male; Methylprednisolone Hemisuccinate; Pemphig | 1983 |
Unusual immunofluorescence findings in pemphigus vegetans.
Topics: Aged; Complement C3; Fluorescent Antibody Technique; Humans; Immunoglobulin G; Male; Pemphigus; Pred | 1983 |
Pemphigus vegetans. Neumann type and Hallopeau type.
Topics: Abscess; Acantholysis; Fluorescent Antibody Technique; Groin; Humans; Immunoglobulin M; Male; Middle | 1984 |
[Post-mortem evaluation in endemic pemphigus foliaceus and pemphigus vulgaris].
Topics: Adolescent; Adult; Aged; Bacterial Infections; Child; Female; Humans; Male; Middle Aged; Pemphigus; | 1984 |
[Pemphigus herpetiformis].
Topics: Adult; Azathioprine; Biopsy; Drug Therapy, Combination; Fluorescent Antibody Technique; Humans; Male | 1984 |
Autoantibodies to epithelial cells (intercellular substance) and their correlation with clinical activity of pemphigus vulgaris.
Topics: Adult; Aged; Autoantibodies; Epithelium; Extracellular Matrix; Female; Fluorescent Antibody Techniqu | 1984 |
Pemphigus vulgaris: results of treatment with gold as a steroid-sparing agent in a series of thirteen patients.
Topics: Adult; Aged; Aurothioglucose; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug T | 1984 |
Juvenile pemphigus vulgaris.
Topics: Adolescent; Age Factors; Azathioprine; Diagnosis, Differential; Drug Therapy, Combination; Humans; M | 1984 |
[Case of pemphigus of the oral mucosa with complete remission after treatment with corticosteroids and immunosuppressive agents].
Topics: Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Middle Aged; Mouth Diseases; Pemphigus; | 1984 |
[Continuous plasma filtration. Experiences in the treatment of pemphigus vulgaris].
Topics: Adult; Autoantibodies; Azathioprine; Combined Modality Therapy; Complement System Proteins; Extracel | 1984 |
Treatment of pemphigus vulgaris. Results obtained in 84 patients between 1961 and 1982.
Topics: Azathioprine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Pemphigus; Predni | 1984 |
Surgical approach to the treatment of refractory lesions of pemphigus vulgaris.
Topics: Adult; Drug Resistance; Humans; Lip Diseases; Male; Pemphigus; Prednisone; Thrombophlebitis | 1984 |
Pyodermite végétante of Hallopeau. Immunofluorescence studies performed in an early disease stage.
Topics: Animals; Azathioprine; Complement C3; Diagnosis, Differential; Epidermis; Female; Fluorescent Antibo | 1980 |
Plasma exchange in pemphigus. Uncontrolled study of ten patients.
Topics: Aged; Autoantibodies; Female; Humans; Male; Middle Aged; Pemphigus; Plasma Exchange; Prednisone | 1983 |
Pemphigus vulgaris. A study of six cases treated with levamisole and prednisone.
Topics: Adult; Aged; Drug Combinations; Female; Humans; Levamisole; Male; Middle Aged; Mouth Diseases; Pemph | 1982 |
Cell-mediated immunity in patients with less than pemphigus vulgaris greater than before, during and after prolonged treatment with steroids.
Topics: Adult; Aged; Female; Graft vs Host Reaction; Humans; Immunity, Cellular; Male; Middle Aged; Pemphigu | 1981 |
Childhood pemphigus foliaceus. Report of a case.
Topics: Black People; Child, Preschool; Fluorescent Antibody Technique; Humans; Male; Pemphigus; Prednisone; | 1980 |
Acanthosis nigricans developing in resolving lesions of pemphigus vulgaris.
Topics: Acanthosis Nigricans; Adult; Azathioprine; Female; Humans; Pemphigus; Plasmapheresis; Prednisone | 1982 |
Perforation of the colon in high-dose corticosteroid therapy of pemphigus.
Topics: Colonic Diseases; Humans; Intestinal Perforation; Male; Middle Aged; Pemphigus; Prednisone | 1982 |
[Pemphigus in Sénégal (apropos of 40 cases)].
Topics: Adult; Aged; Black People; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male | 1982 |
Death in pemphigus.
Topics: Adrenal Cortex Hormones; Adult; Aged; Female; Humans; Immunity, Cellular; Infections; Male; Middle A | 1982 |
[Similarities and differences between Brazilian wild fire and pemphigus foliaceus Cazenave].
Topics: Adolescent; Adult; Age Factors; Brazil; Child; Diagnosis, Differential; Female; Humans; Male; Middle | 1982 |
Penicillamine-induced pemphigus foliaceus. A fatal outcome.
Topics: Female; Humans; Middle Aged; Pemphigus; Penicillamine; Prednisone | 1981 |
[Pemphigus foliaceus in a child. A two years follow-up under steroid. An immunosuppression therapy (author's transl)].
Topics: Age Factors; Child; Humans; Immunosuppression Therapy; Male; Pemphigus; Prednisone; Sex Factors | 1980 |
Pemphigus foliaceus resembling eruptive seborrheic keratoses.
Topics: Aged; Diagnosis, Differential; Humans; Keratosis; Male; Pemphigus; Prednisone; Skin | 1980 |
Squamous cell carcinoma arising in pemphigus vulgaris during immunosuppressive therapy.
Topics: Adult; Carcinoma, Squamous Cell; Cheek; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; | 1980 |
Pregnancy associated with pemphigus.
Topics: Adult; Autoimmune Diseases; Female; Humans; Pemphigus; Prednisone; Pregnancy; Pregnancy Complication | 1995 |
The treatment of pemphigus vulgaris. Experience with 48 patients seen over an 11-year period.
Topics: Anti-Inflammatory Agents; Azathioprine; Drug Administration Schedule; Drug Therapy, Combination; Fol | 1995 |
Sulfone syndrome in a patient receiving steroids for pemphigus.
Topics: Aged; Chemical and Drug Induced Liver Injury; Dapsone; Drug Hypersensitivity; Drug Therapy, Combinat | 1994 |
[Cutaneous Alternaria infection occurring in the course of a treated pemphigus].
Topics: Aged; Alternaria; Dermatomycoses; Humans; Male; Opportunistic Infections; Pemphigus; Prednisone | 1994 |
[Detection of an unusual varicella zoster virus infection in an immunosuppressed patient with polymerase chain reaction].
Topics: Acyclovir; Aged; Azathioprine; Chickenpox; Cytopathogenic Effect, Viral; Female; Herpesvirus 3, Huma | 1994 |
Erythema annulare-like acantholytic dermatosis (EAAD): nonbullous pemphigus or a new entity?
Topics: Acantholysis; Aged; Biopsy; Diagnosis, Differential; Female; Humans; Immunoglobulin G; Pemphigus; Pr | 1993 |
The efficacy of combined treatment with prednisone and cyclosporine in patients with pemphigus: preliminary study.
Topics: Administration, Oral; Adult; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Gin | 1994 |
Feasibility of a registry of pemphigus in Italy: two years experience. Gruppo Italiano Studi Epidemiologici in Dermatologia (GISED)
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Feasibility Studies; Female; Fluorescent Antibody | 1993 |
[Tunisian pemphigus. Apropos of 70 cases. (Experience of the dermatology department of La Rabta Hospital 1974-1992)].
Topics: Adult; Anti-Inflammatory Agents; Female; Humans; Male; Middle Aged; Pemphigus; Prednisone; Retrospec | 1996 |
Coexistence of superficial pemphigus and psoriasis.
Topics: Anti-Inflammatory Agents; Antigenic Modulation; Autoimmune Diseases; Dapsone; Erythema; Etretinate; | 1996 |
Bilateral herpes simplex virus keratitis in a patient with pemphigus vulgaris.
Topics: Aged; Glucocorticoids; Humans; Keratitis, Herpetic; Male; Opportunistic Infections; Pemphigus; Predn | 1996 |
Treatment of pemphigus vulgaris with brief, high-dose intravenous glucocorticoids.
Topics: Administration, Oral; Adult; Aged; Anti-Inflammatory Agents; Case-Control Studies; Female; Follow-Up | 1996 |
Pulse glucocorticoid therapy. The 'big shot' revisited.
Topics: Administration, Oral; Anti-Inflammatory Agents; Biological Availability; Body Weight; Dexamethasone; | 1996 |
[Paraneoplastic pemphigus in chronic lymphocytic leukemia].
Topics: Glucocorticoids; Humans; Immunohistochemistry; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle | 1996 |
Graves' hyperthyroidism and ophthalmopathy associated with pemphigus vulgaris: onset of thyroid autoimmune disease during chronic low-dose glucocorticoid therapy.
Topics: Adult; Drug Administration Schedule; Female; Graves Disease; Humans; Iodine Radioisotopes; Methimazo | 1997 |
Pemphigus vulgaris in older adults.
Topics: Age Distribution; Age of Onset; Aged; Disease Progression; Female; Glucocorticoids; Humans; Male; Pe | 1998 |
Invasive cutaneous aspergillosis complicating immunosuppressive therapy for recalcitrant pemphigus vulgaris.
Topics: Adult; Aspergillosis; Azathioprine; Cyclophosphamide; Cyclosporine; Dermatomycoses; Fatal Outcome; F | 1998 |
Pemphigus Area and Activity Score (PAAS)--a novel clinical scoring method for monitoring of pemphigus vulgaris patients.
Topics: Glucocorticoids; Humans; Pemphigus; Prednisone; Severity of Illness Index | 1998 |
Tufted hair folliculitis developing in a recalcitrant lesion of pemphigus vulgaris.
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents; Chronic Disease; Folliculitis; Glucocorticoid | 1998 |
A patient with acquired haemophilia A and pemphigus.
Topics: Aged; Factor VIII; Follow-Up Studies; Glucocorticoids; Hematoma; Hemophilia A; Humans; Leg; Male; Pe | 1998 |
Paraneoplastic pemphigus as the presenting symptom of a lymphoma of the tongue.
Topics: Aged; Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Azathioprine; Cyclop | 1998 |
Severe nonendemic pemphigus foliaceus presenting in the postpartum period.
Topics: Adult; Anti-Inflammatory Agents; Autoantigens; Cadherins; Cyclophosphamide; Desmoglein 1; Female; Fl | 1999 |
Mycophenolate mofetil: a new therapeutic option in the treatment of blistering autoimmune diseases.
Topics: Aged; Aged, 80 and over; Autoimmune Diseases; Drug Therapy, Combination; Female; Glucocorticoids; Hu | 1999 |
Pemphigus erythematosus associated with thymoma: a case report.
Topics: Cicatrix; Dapsone; Drug Therapy, Combination; Humans; Male; Middle Aged; Pemphigus; Postoperative Co | 1999 |
First one, then two blistering eruptions.
Topics: Aged; Anti-Inflammatory Agents; Diagnosis, Differential; Female; Humans; Pemphigus; Prednisone | 1999 |
The use of chlorambucil with prednisone in the treatment of pemphigus.
Topics: Adult; Aged; Alkylating Agents; Chlorambucil; Drug Therapy, Combination; Female; Glucocorticoids; Hu | 2000 |
Atypical herpes simplex can mimic a flare of disease activity in patients with pemphigus vulgaris.
Topics: Aged; Anti-Inflammatory Agents; Deglutition Disorders; Diagnosis, Differential; Female; Glucocortico | 1999 |
[A clinical analysis of 64 cases of pemphigus].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cyclophosphamide; Drug Therapy, Combination; Female; Glu | 1998 |
[Paraneoplastic pemphigus: a pustular form during chronic lymphoid leukemia].
Topics: Anti-Inflammatory Agents; Antineoplastic Agents, Alkylating; Biopsy; Chlorambucil; Drug Therapy, Com | 2001 |
Avascular bone necrosis. A complication of long-term corticosteroid therapy.
Topics: Adrenocorticotropic Hormone; Female; Femur Head Necrosis; Glucocorticoids; Humans; Humerus; Middle A | 1965 |
[Association of seborrheic pemphigus and Hashimoto autoimmune thyroiditis. Apropos of a further case].
Topics: Aged; Anti-Inflammatory Agents; Biopsy; Cyclophosphamide; Dermatitis, Seborrheic; Drug Therapy, Comb | 2002 |
Two cases of penicillamine-induced pemphigus erythematosus.
Topics: Aged; Arthritis, Rheumatoid; Azathioprine; Drug Eruptions; Female; Humans; Middle Aged; Pemphigus; P | 1979 |
Herpesvirus hominis hepatitis and disseminated intravascular coagulation. Occurrence in an adult with pemphigus vulgaris.
Topics: Adolescent; Adult; Cyclophosphamide; Disseminated Intravascular Coagulation; Female; Hepatitis, Vira | 1976 |
[Kaposi's herpes eczema in pemphigus foliaceus].
Topics: Adult; Female; Humans; Kaposi Varicelliform Eruption; Pemphigus; Prednisone; Simplexvirus; Triamcino | 1977 |
Prosthetic management of patients with pemphigus vulgaris.
Topics: Aged; Denture, Complete, Upper; Denture, Partial, Removable; Female; Humans; Mouth Diseases; Pemphig | 1977 |
Intraoral pemphigus vulgaris.
Topics: Acantholysis; Age Factors; Body Weight; Diagnosis, Differential; Female; Follow-Up Studies; Humans; | 1977 |
Disseminated superficial porokeratosis in patients with pemphigus vulgaris treated with steroids.
Topics: Female; Humans; Keratosis; Male; Middle Aged; Pemphigus; Prednisone; Skin; Smoking | 1979 |
[Treatment of pemphigus].
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Female; Humans; Male; Middle Aged; Pemphigus; Pred | 1977 |
Childhood pemphigus treated with gold.
Topics: Adrenal Cortex Hormones; Adult; Antibodies; Aurothioglucose; Child; Child, Preschool; Drug Therapy, | 1978 |
[Experience with prophylactic medical care of vesiculobullous diseases (author's transl)].
Topics: Ambulatory Care; Antineoplastic Agents; Czechoslovakia; Dermatitis Herpetiformis; Humans; Pemphigus; | 1978 |
Evaluation and management of diseases of the vulva: bullous diseases.
Topics: Dermatitis Herpetiformis; Diagnosis, Differential; Erythema Multiforme; Female; Fluorescent Antibody | 1978 |
Correlation of antibodies in skin and serum with disease severity in pemphigus.
Topics: Antibodies; Fluorescent Antibody Technique; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobul | 1979 |
Plasmapheresis and immunosuppressive therapy. Effect on levels of intercellular antibodies in pemphigus vulgaris.
Topics: Autoantibodies; Blood Cell Count; Blood Platelets; Cyclophosphamide; Female; Humans; Immunosuppressi | 1979 |
Pemphigus vulgaris in adolescence.
Topics: Adult; Age Factors; Child; Humans; Male; Pemphigus; Prednisone | 1979 |
Pemphigus in El Salvador. An eight-year study (1970-1977).
Topics: Adolescent; Adult; Aged; Chloroquine; El Salvador; Female; Humans; Male; Middle Aged; Pemphigus; Pre | 1979 |
Dapsone in the treatment of pemphigus vulgaris.
Topics: Adult; Dapsone; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Pemp | 1978 |
On the mechanism of corticosteroid-induced ocular hypertension.
Topics: Acetazolamide; Aqueous Humor; Dexamethasone; Epinephrine; Female; Glaucoma; Humans; Hyaluronoglucosa | 1978 |
Successful use of cyclophosphamide and prednisone for initial treatment of pemphigus vulgaris.
Topics: Adult; Aged; Azathioprine; Child; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Male; | 1978 |
Lymphomatoid granulomatosis after immunosuppression for pemphigus.
Topics: Aged; Autopsy; Azathioprine; Granuloma; Humans; Immunosuppressive Agents; Lung; Lymphoma; Male; Pemp | 1978 |
Pemphigus and coccidioidomycosis.
Topics: Adult; Coccidioides; Coccidioidomycosis; Humans; Male; Middle Aged; Pemphigus; Prednisone | 1978 |
International mortality from bullous diseases since 1950.
Topics: Adult; Age Factors; Aged; Chlortetracycline; Cortisone; Denmark; Dermatitis Herpetiformis; Female; F | 1976 |
Pemphigus and pemphigoid: dermatologic examples of type II immune reactivity.
Topics: Adrenal Cortex Hormones; Antigen-Antibody Reactions; Fluorescent Antibody Technique; Humans; Immunog | 1976 |
Pemphigus and myasthenia gravis.
Topics: Animals; Antibodies, Antinuclear; Autoantibodies; Cattle; Complement C1; Complement C3; Cross Reacti | 1975 |
Pemphigus: a 20-year review of 107 patients treated with corticosteroids.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Aged; Autoimmune Diseases; Dose-Response Relationship, D | 1976 |
Management of pemphigus with gold compounds: a long-term follow-up report.
Topics: Adult; Aged; Aurothioglucose; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; F | 1976 |
Pemphigus vulgaris, large dose glucocorticoid therapy and staphylococcal bacteremia.
Topics: Female; Humans; Inflammation; Middle Aged; Pemphigus; Pneumonia, Staphylococcal; Prednisone; Sepsis; | 1977 |
Immunosuppressants and prednisone in pemphigus vulgaris: therapeutic results obtained in 63 patients between 1961 and 1975.
Topics: Adult; Aged; Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Immunosuppre | 1977 |
Pemphigus foliaceus. Early clinical appearance as dermatitis herpetiformis with eosinophilic spongiosis.
Topics: Acantholysis; Cytarabine; Dermatitis Herpetiformis; Diagnosis, Differential; Eosinophils; Female; He | 1976 |
Pemphigus induced by rifampicin.
Topics: Aged; Chemical and Drug Induced Liver Injury; Female; Humans; Liver Function Tests; Pemphigus; Predn | 1976 |
Periadenitis mucosa necrotica recurrens.
Topics: Anesthetics; Cineradiography; Diagnosis, Differential; Erythromycin; Granuloma, Lethal Midline; Gran | 1975 |
Corticosteroids in diseases of the oral mucosa.
Topics: Administration, Topical; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Epidermolysis Bullosa; E | 1976 |
Vesiculobullous eruptions can cause serious problems.
Topics: Adult; Aged; Blister; Diagnosis, Differential; Humans; Immunosuppressive Agents; Middle Aged; Pemphi | 1975 |
Pemphigus: combined treatment with methotrexate and prednisone.
Topics: Adolescent; Adult; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Middle Aged; Pemph | 1975 |
Pemphigus vulgaris and disseminated coccidioidomycosis.
Topics: Azathioprine; Betamethasone; Coccidioidomycosis; Humans; Immunosuppressive Agents; Male; Middle Aged | 1976 |
Cyclophosphamide plus vincristine and prednisone in the treatment of severe pemphigus vulgaris refractory to conventional therapy.
Topics: Adolescent; Aged; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pe | 1992 |
Pemphigus vulgaris.
Topics: Female; Humans; Middle Aged; Mouth Diseases; Pemphigus; Prednisone | 1992 |
Pemphigus foliaceus. Use of antimalarial agents as adjuvant therapy.
Topics: Aged; Azathioprine; Chemotherapy, Adjuvant; Female; Humans; Hydroxychloroquine; Male; Middle Aged; P | 1992 |
Paraneoplastic pemphigus, cicatricial conjunctivitis, and acanthosis nigricans with pachydermatoglyphy in a patient with bronchogenic squamous cell carcinoma.
Topics: Acanthosis Nigricans; Aged; Azathioprine; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Chronic | 1992 |
Endosteal implants in a patient with corticosteroid dependence.
Topics: Alveolar Process; Dental Implantation, Endosseous; Dental Implants; Female; Humans; Middle Aged; Ost | 1991 |
The role of cyclosporine A in the treatment of pemphigus erythematosus.
Topics: Adult; Cyclosporine; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pemphigus; Predni | 1991 |
[Chronic ulceration of the oral mucosa. Description of a case].
Topics: Acantholysis; Biopsy; Chronic Disease; Humans; Male; Middle Aged; Mouth Diseases; Mouth Mucosa; Pemp | 1991 |
Diabetes mellitus induced in a dog after administration of corticosteroids and methylprednisolone pulse therapy.
Topics: Administration, Oral; Adrenal Cortex Hormones; Animals; Azathioprine; Dexamethasone; Diabetes Mellit | 1991 |
[Vulvovaginal and cervix uteri involvement disclosing pemphigus vulgaris. Efficacy of gold salt therapy].
Topics: Adult; Antirheumatic Agents; Azathioprine; Female; Humans; Organogold Compounds; Pemphigus; Predniso | 1990 |
Treatment of pemphigus.
Topics: Adult; Cyclophosphamide; Female; Humans; Male; Pemphigus; Prednisolone; Prednisone; Recurrence | 1991 |
Juvenile pemphigus vulgaris.
Topics: Adolescent; Female; Humans; Pemphigus; Prednisone; Prognosis | 1991 |
[Usefulness of cyclosporin in the treatment of pemphigus vulgaris. Apropos of 3 cases].
Topics: Administration, Oral; Adult; Aged; Child; Cyclosporins; Drug Evaluation; Drug Therapy, Combination; | 1991 |
Immunosuppressive therapy of pemphigus vulgaris complicated by Nocardia pneumonia. Gold as an alternate therapy.
Topics: Azathioprine; Candidiasis; Female; Gold Sodium Thiomalate; Humans; Injections, Intramuscular; Middle | 1990 |
Familial pemphigus vulgaris.
Topics: Adult; Complement C3; Female; Fluorescent Antibody Technique; HLA Antigens; Humans; Immunoglobulin G | 1990 |
Extracorporeal photochemotherapy for drug-resistant pemphigus vulgaris.
Topics: Aged; Autoimmune Diseases; Azathioprine; Combined Modality Therapy; Drug Resistance; Female; Humans; | 1990 |
Periodontal alterations in patients with pemphigus vulgaris taking steroids. A biannual assessment.
Topics: Adolescent; Adult; Alveolar Process; Bone Resorption; Dental Calculus; Dental Plaque Index; Female; | 1990 |
Kaposi's sarcoma after steroid therapy for pemphigus foliaceus.
Topics: Adult; Humans; Male; Pemphigus; Prednisone; Sarcoma, Kaposi | 1989 |
The usefulness of immunofluorescent tests in pemphigus patients in clinical remission.
Topics: Adult; Aged; Complement C3; Female; Fluorescent Antibody Technique; Humans; Immunoglobulin G; Male; | 1989 |
Coexistence of pemphigus foliaceus and Sheehan's syndrome: a case report.
Topics: Administration, Oral; Female; Humans; Hypopituitarism; Middle Aged; Pemphigus; Prednisone | 1989 |
Dermatologic emergencies.
Topics: Aged; Dermatitis, Contact; Dermatitis, Exfoliative; Emergencies; Erythema; Histamine H1 Antagonists; | 1986 |
[Therapy of pemphigus. Critical remarks based on 44 clinical cases].
Topics: Adrenocorticotropic Hormone; Adult; Aged; Azathioprine; Cyclophosphamide; Drug Therapy, Combination; | 1985 |
Chronic benign familial pemphigus.
Topics: Adult; Betamethasone; Chronic Disease; Diagnosis, Differential; Drug Therapy, Combination; Female; F | 1988 |
Oral gold therapy (Auranofin) in pemphigus vulgaris.
Topics: Administration, Oral; Adult; Auranofin; Aurothioglucose; Cyclophosphamide; Dapsone; Female; Gold; Hu | 1986 |
Juvenile pemphigus vulgaris: a 4- to 19-year follow-up of 4 patients.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Child; Female; Follow-Up Studies; Humans; I | 1988 |
The course and prognosis of pemphigus. A review of 115 patients.
Topics: Adult; Age Factors; Azathioprine; Cause of Death; Drug Therapy, Combination; Female; Follow-Up Studi | 1988 |
Pemphigus vulgaris. Combined treatment with intravenous corticosteroid pulse therapy, plasmapheresis, and azathioprine.
Topics: Adolescent; Antigen-Antibody Complex; Autoantibodies; Azathioprine; Combined Modality Therapy; Drug | 1988 |
Treatment of nine cases of pemphigus vulgaris with cyclosporine.
Topics: Administration, Oral; Adult; Aged; Cyclosporins; Drug Combinations; Female; Humans; Male; Middle Age | 1988 |
South American pemphigus foliaceus: study of an epidemic in El Bagre and Nechi, Colombia 1982 to 1986.
Topics: Adult; Aged; Aged, 80 and over; Colombia; Disease Outbreaks; Female; Humans; Male; Methotrexate; Met | 1988 |
[Therapy of pemphigus and pemphigoid].
Topics: Azathioprine; Cyclophosphamide; Drug Therapy, Combination; Humans; Methotrexate; Pemphigoid, Bullous | 1986 |
[Cyclosporin A in the treatment of pemphigus foliaceus and pemphigus erythematosus].
Topics: Complement C3; Cyclosporins; Drug Therapy, Combination; Female; Fluorescent Antibody Technique; Huma | 1986 |
Neonatal pemphigus vulgaris: transplacental transmission of antibodies.
Topics: Adult; Azathioprine; Female; Fluorescent Antibody Technique; Humans; Immunity, Maternally-Acquired; | 1986 |
Childhood pemphigus foliaceus: case report and review of the literature.
Topics: Administration, Topical; Anti-Inflammatory Agents; Child, Preschool; Colorado; Glucocorticoids; Huma | 1986 |
Juvenile pemphigus vulgaris. A case report.
Topics: Adolescent; Humans; Male; Pemphigus; Prednisone | 1987 |
Hyperinfection with Strongyloides during treatment of pemphigus vulgaris.
Topics: Humans; Male; Middle Aged; Pemphigus; Prednisone; Schizophrenia; Strongyloidiasis | 1987 |
Use of cyclophosphamide in azathioprine failures in pemphigus.
Topics: Adult; Aged; Azathioprine; Cyclophosphamide; Dapsone; Drug Therapy, Combination; Female; Humans; Mal | 1987 |
Estimation of prednisone intake in pemphigus vulgaris patients with the use of simple laboratory methods.
Topics: 17-Hydroxycorticosteroids; Aged; Female; Humans; Hydrocortisone; Male; Middle Aged; Pemphigus; Predn | 1987 |
Pemphigus foliaceus coexisting with toxic, multinodular goiter.
Topics: Adult; Combined Modality Therapy; Drug Therapy, Combination; Female; Goiter, Nodular; Humans; Iodine | 1986 |
Chronic balanitis owing to pemphigus vegetans.
Topics: Aged; Balanitis; Chronic Disease; Humans; Male; Pemphigus; Prednisone; Triamcinolone | 1987 |
Pemphigus foliaceus in dogs: a review of 37 cases.
Topics: Animals; Dog Diseases; Dogs; Female; Fluorescent Antibody Technique; Immunosuppressive Agents; Male; | 1985 |
Pemphigus foliaceus of the footpads in three dogs.
Topics: Animals; Dog Diseases; Dogs; Female; Foot Dermatoses; Male; Pemphigus; Prednisone | 1985 |
[Pemphigus in Israel].
Topics: Adult; Aged; Ethnicity; Follow-Up Studies; Humans; Israel; Middle Aged; Pemphigus; Prednisone | 1985 |
Macroglossia. An unusual presentation of pemphigus vulgaris.
Topics: Adult; Desoximetasone; Diagnosis, Differential; Female; Humans; Immunoglobulin G; Macroglossia; Pemp | 1985 |
[Plasmapheresis in the treatment of pemphigus].
Topics: Adult; Antibodies; Combined Modality Therapy; Cyclophosphamide; Drug Therapy, Combination; Female; H | 1985 |
Drug-induced arthropathy and necrosis of the femoral head.
Topics: Adult; Aged; Alcoholism; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Asthma; Bone Regeneration; | 1973 |
Clinical significance of autoantibodies in pemphigus.
Topics: Aged; Autoantibodies; Betamethasone; Blood; Cortisone; Female; Fluorescent Antibody Technique; Human | 1966 |
Gold sodium thiomalate treatment of pemphigus.
Topics: Adult; Aged; Agranulocytosis; Antibodies; Dermatitis; Epithelium; Erythema Nodosum; Female; Gold; Go | 1973 |
Eosinophilic spongiosis in pemphigus. A report of an unusual hitological change in pemphigus.
Topics: Adrenocorticotropic Hormone; Aged; Dapsone; Dermatitis Herpetiformis; Diagnosis, Differential; Eczem | 1968 |
Pemphigus foliaceus or erythema multiforme.
Topics: Adrenocorticotropic Hormone; Autoantibodies; Child, Preschool; Diagnosis, Differential; Erythema Mul | 1968 |
Studies in bullous diseases. Immunofluorescent serologic tests.
Topics: Adrenocorticotropic Hormone; Adult; Antibodies, Antinuclear; Autoantibodies; Basement Membrane; Blis | 1968 |
[Value of combined quinacrine-aureomycin-corticotherapy in pemphigus: pemphigus vulgaris, followed for 8 years, cured at the present time; seborrheic pemphigus followed for 14 years with stabilization verging on cure].
Topics: Adrenocorticotropic Hormone; Chlortetracycline; Dermatitis, Seborrheic; Drug Synergism; Humans; Male | 1968 |
Azathioprine in pemphigus vulgaris.
Topics: Adrenocorticotropic Hormone; Adult; Aged; Azathioprine; Drug Hypersensitivity; Female; Humans; Male; | 1970 |
Pemphigus vulgaris and internal malignancy.
Topics: Adenocarcinoma, Scirrhous; Adult; Aged; Breast Neoplasms; Carcinoma, Squamous Cell; Dexamethasone; F | 1974 |
Fatal herpes hepatitis associated with pemphigus vulgaris and steroids in an adult.
Topics: Female; Hepatitis A; Herpes Simplex; Herpesviridae; Herpesviridae Infections; Humans; Liver; Microsc | 1974 |
Pemphigus vulgaris: the role of the dentist in its management.
Topics: Cytodiagnosis; Facial Dermatoses; Humans; Male; Middle Aged; Mouth Diseases; Pemphigus; Prednisone; | 1972 |
Methotrexate and prednisone in pemphigus vulgaris. Therapeutic results obtained in 36 patients between 1961 and 1970.
Topics: Administration, Oral; Adult; Aged; Antibodies; Female; Fluorescent Antibody Technique; Humans; Injec | 1972 |
Pemphigus treatment with azathioprine. Clinical and immunologic correlation.
Topics: Adult; Aged; Antibodies; Azathioprine; Blood Platelets; Dose-Response Relationship, Drug; Fatigue; F | 1973 |
Pemphigus vulgaris in a 3-and-one-half-year old boy.
Topics: Biopsy; Child, Preschool; Fluorescent Antibody Technique; Fundus Oculi; Growth Disorders; Humans; Ma | 1973 |
Familial occurrence of pemphigus foliaceus.
Topics: Adult; Antibodies; Antimalarials; Biopsy; Female; Fluorescent Antibody Technique; Humans; Male; Pemp | 1973 |
Mixed bullous disease.
Topics: Adolescent; Aged; Antibodies; Blister; Dapsone; Dermatitis Herpetiformis; Diagnosis, Differential; F | 1974 |
Herpes gestationis. New immunologic findings.
Topics: Adult; Animals; Antibodies; Basement Membrane; Biopsy; Complement System Proteins; Dermatitis Herpet | 1974 |
Pemphigus. Epidemiologic and survival characteristics of 59 patients, 1955-1973.
Topics: Adolescent; Adult; Age Factors; Aged; California; Child; Cortisone; Cyclophosphamide; Female; Fluore | 1974 |
Cyclophosphamide in the treatment of pemphigus vulgaris and bullous pemphigoid.
Topics: Adult; Aged; Alopecia; Cataract; Child; Cyclophosphamide; Diabetes Mellitus; Female; Humans; Leukope | 1972 |
[Pemphigus of the mucosa].
Topics: Aged; Female; Humans; Laryngeal Edema; Mouth Mucosa; Nasal Mucosa; Pemphigus; Prednisone; Stomatitis | 1972 |
Treatment of pemphigus and pemphigoid with azathioprine.
Topics: Aged; Azathioprine; Candidiasis, Cutaneous; Drug Therapy, Combination; Female; Follow-Up Studies; Hu | 1973 |
Pemphigus and Hodgkin's disease.
Topics: Acantholysis; Adult; Biopsy; Blister; Cyclophosphamide; Hodgkin Disease; Humans; Lymph Nodes; Male; | 1974 |
Azathioprine for pemphigus and pemphigoid--a 4 year follow-up.
Topics: Adult; Aged; Anemia; Azathioprine; Bone Neoplasms; Drug Evaluation; Drug Hypersensitivity; Female; F | 1974 |
Intermittent cyclophosphamide in pemphigus vulgaris and bullous pemphigoid.
Topics: Administration, Oral; Aged; Cyclophosphamide; Female; Humans; Infusions, Parenteral; Male; Methods; | 1974 |
Atypical myocardial infarction in a case of pemphigus in the light of immunofluorescence studies.
Topics: Autoantibodies; Electrocardiography; Fluorescent Antibody Technique; Humans; Myocardial Infarction; | 1969 |
The etiology and treatment of pemphigus and pemphigoid.
Topics: Autoimmune Diseases; Fluorescent Antibody Technique; Humans; Methotrexate; Microscopy, Electron; Pem | 1969 |
Immunofluorescent studies of pemphigus foliaceus in a child.
Topics: Antibodies; Antibodies, Antinuclear; Child, Preschool; Fluorescent Antibody Technique; Humans; Male; | 1969 |
Immunofluorescent "band" test for lupus erythematosus. II. Employing skin lesions.
Topics: Antibodies, Antinuclear; Basement Membrane; Chloroquine; Collagen Diseases; Fluorescent Antibody Tec | 1970 |
Chronic cutaneous herpes simplex.
Topics: Adult; Agammaglobulinemia; Chronic Disease; Facial Dermatoses; Herpes Simplex; Hodgkin Disease; Huma | 1971 |
[Coexistence of pemphigus erythematosus and myasthenia gravis].
Topics: Adult; Antibodies, Antinuclear; Dexamethasone; Female; Fluorescent Antibody Technique; Humans; Myast | 1970 |
Fascial space infection in a patient with pemphigus.
Topics: Abscess; Adult; Humans; Interprofessional Relations; Ludwig's Angina; Male; Mouth Diseases; Pemphigu | 1967 |
Hyperosmolar hyperglycemic non-ketotic coma: its importance in surgical problems.
Topics: Aged; Burns; Coma; Dehydration; Diabetes Mellitus; Diabetic Ketoacidosis; Diagnosis, Differential; F | 1968 |
[A case of meningitis due to listeria monocytogenes developing during corticosteroid treatment].
Topics: Aged; Agglutination Tests; Diabetes Mellitus; Humans; Listeria monocytogenes; Listeriosis; Male; Men | 1969 |
[Diseases of the external female genitalia. Vesicular diseases with vulvar involvement].
Topics: Acantholysis; Adrenal Cortex Hormones; Aged; Dermatitis Herpetiformis; Diagnosis, Differential; Fema | 1971 |
Pemphigus vulgaris in childhood.
Topics: Acantholysis; Child; Female; Humans; Mouth Diseases; Oral Manifestations; Pemphigus; Prednisone; Ski | 1972 |
Occult lung abscess complicating high-dosage corticosteroid therapy.
Topics: Adult; Ampicillin; Humans; Lung Abscess; Male; Middle Aged; Pemphigus; Penicillins; Prednisone; Radi | 1972 |
[Treatment of pemphigus and parapemphigus].
Topics: Aged; Antibodies; Antimetabolites; Female; Humans; Immunosuppressive Agents; Male; Mercaptopurine; M | 1972 |
Childhood pemphigus vulgaris.
Topics: Adolescent; Antibodies; Biopsy; Diagnosis, Differential; Female; Humans; Mouth Diseases; Mouth Mucos | 1972 |
Pathogenesis and management of autoimmune diseases of the skin.
Topics: Antimalarials; Autoimmune Diseases; Fluocinolone Acetonide; Humans; Immunosuppressive Agents; Lupus | 1972 |
Subcutaneous Trichophyton rubrum abscesses. A case report.
Topics: Abscess; Adrenal Cortex Hormones; Dermatomycoses; Female; Folliculitis; Griseofulvin; Humans; Middle | 1971 |
Alternate-day corticosteroid regimen.
Topics: 17-Hydroxycorticosteroids; Adolescent; Adrenal Glands; Adult; Aged; Body Weight; Child; Child, Presc | 1971 |
[A case of pemphigus induced by D-penicillamine. Does iatrogenic pemphigus exist?].
Topics: Arthritis, Rheumatoid; Autoantibodies; Biopsy; Cytodiagnosis; Drug Synergism; Female; Fluorescent An | 1971 |
[Seborrheic pemphigus: atypical histologic beginning. Value of the immunology].
Topics: Adult; Autoantibodies; Biopsy; Diagnosis, Differential; Humans; Immunosuppression Therapy; Male; Pem | 1971 |
Oral pemphigus vulgaris.
Topics: Dentistry; Pemphigus; Prednisone; Vitamins | 1966 |
Hazards of systemic corticosteroid therapy.
Topics: Abdomen, Acute; Aged; Diabetes Mellitus; Female; Humans; Hypertension; Middle Aged; Mouth Diseases; | 1971 |
[Various cases of pemphigus (treatment with corticosteroids + immunosuppressive agents)].
Topics: Adult; Aged; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Pemphigus; P | 1969 |
[Immunosuppressive therapy in pemphigus vulgaris].
Topics: Adult; Aged; Azathioprine; Desoxycorticosterone; Female; Humans; Immunosuppressive Agents; Male; Mer | 1970 |
Pemphigus and herpes simplex. Antibody response to corticosteroids in a patient.
Topics: Antibody Formation; Autoantibodies; Herpes Simplex; Humans; Immunoglobulins; Male; Middle Aged; Pemp | 1970 |
Remarks on the treatment of pemphigus vulgaris.
Topics: Adrenal Cortex Hormones; Age Factors; Europe, Eastern; Female; Humans; Israel; Jews; Male; Methotrex | 1970 |
Pemphigus vulgaris.
Topics: Adult; Antibodies; Humans; Male; Methotrexate; Pemphigus; Prednisone | 1970 |
[Treatment of malignant pemphigus with azathiorpine].
Topics: Adult; Azathioprine; Female; Humans; Male; Middle Aged; Pemphigus; Prednisone | 1970 |
Cyclophosphamide and pemphigus vulgaris.
Topics: Adrenal Cortex Hormones; Blood Protein Electrophoresis; Cyclophosphamide; Diabetes Complications; Hu | 1971 |
Alternate-day prednisone therapy for pemphigus vulgaris. Preliminary report.
Topics: 17-Hydroxycorticosteroids; Administration, Oral; Adult; Aged; Antibodies; Female; Humans; Hydrocorti | 1971 |
Refractory involvement of cervix uteri in a case of pemphigus vulgaris.
Topics: Female; Humans; Middle Aged; Pemphigus; Prednisone; Uterine Cervical Erosion; Vaginal Smears | 1971 |
[On the problem of dermarcation of the Lyell's syndrome].
Topics: Dermatitis Herpetiformis; Diagnosis, Differential; Female; Humans; Middle Aged; Pemphigus; Prednison | 1967 |
[Vegetative pemphigus with unusual complications and with terminal adrenal insufficiency].
Topics: Adrenal Insufficiency; Humans; Male; Meningitis, Listeria; Middle Aged; Pemphigus; Prednisone; Tinea | 1968 |
Pemphigus vulgaris-vegetans.
Topics: Female; Fluocinolone Acetonide; Humans; Middle Aged; Pemphigus; Prednisone | 1969 |
[Basal cell carcinoma of the skin in a pemphygoid blister. (Case report)].
Topics: Aged; Anti-Bacterial Agents; Carcinoma, Basal Cell; Humans; Male; Pemphigus; Prednisone; Skin Neopla | 1969 |
Pemphigus vulgaris.
Topics: Aged; Female; Humans; Pemphigus; Prednisone | 1969 |
Management of pemphigus vulgaris during pregnancy.
Topics: Adult; Estriol; Female; Humans; Maternal-Fetal Exchange; Pemphigus; Prednisone; Pregnancy; Pregnancy | 1969 |
Urinary oestriol excretion in pregnant patient given large doses of prednisone.
Topics: Adult; Estriol; Female; Fetal Death; Fetus; Humans; Pemphigus; Prednisone; Pregnancy; Pregnancy Comp | 1969 |
Pemphigus vulgaris.
Topics: Aged; Azathioprine; Female; Humans; Pemphigus; Prednisone | 1969 |
Treatment of pemphigus vulgaris with methotrexate.
Topics: Adult; Aged; Antibodies; Female; Humans; Male; Methotrexate; Pemphigus; Prednisone | 1969 |